{
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "# Isolating Gamma vs Kappa Effects on AUC\n",
        "\n",
        "This notebook runs predictions with different combinations of fixed/free gamma and kappa to isolate which parameter causes the AUC drop.\n",
        "\n",
        "**Configurations:**\n",
        "1. **Original**: phi fixed, gamma free, kappa free (already run)\n",
        "2. **Fixed gamma, free kappa**: phi fixed, gamma fixed, kappa free (NEW - run 5 batches)\n",
        "3. **Fixed kappa, free gamma**: phi fixed, gamma free, kappa fixed (NEW - run 5 batches)\n",
        "4. **Fixed both**: phi fixed, gamma fixed, kappa fixed (already run)\n",
        "\n",
        "**Goal**: Compare AUCs to see which parameter (gamma or kappa) is causing the drop."
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {},
      "outputs": [],
      "source": [
        "import subprocess\n",
        "import sys\n",
        "import os\n",
        "from pathlib import Path\n",
        "\n",
        "# Paths\n",
        "base_dir = Path('/Users/sarahurbut/aladynoulli2/claudefile')\n",
        "data_dir = '/Users/sarahurbut/Library/CloudStorage/Dropbox-Personal/data_for_running/'\n",
        "master_path = data_dir + 'master_for_fitting_pooled_correctedE.pt'\n",
        "pooled_gk_path = data_dir + 'pooled_kappa_gamma.pt'\n",
        "\n",
        "print(\"Configuration:\")\n",
        "print(f\"  Master checkpoint: {master_path}\")\n",
        "print(f\"  Pooled gamma/kappa: {pooled_gk_path}\")\n",
        "print()"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "## 1. Run Fixed Gamma, Free Kappa (5 batches)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {},
      "outputs": [],
      "source": [
        "# Fixed gamma, free kappa - NOHUP COMMAND\n",
        "script_fixedg_freek = base_dir / 'run_aladyn_predict_with_master_vector_cenosrE_fixedg_freek.py'\n",
        "output_dir_fixedg_freek = '/Users/sarahurbut/Library/CloudStorage/Dropbox/enrollment_predictions_fixedphi_fixedg_freek_vectorized/'\n",
        "\n",
        "print(\"=\"*80)\n",
        "print(\"NOHUP COMMAND: Fixed Gamma, Free Kappa (5 batches)\")\n",
        "print(\"=\"*80)\n",
        "print(\"Run this in terminal:\")\n",
        "print()\n",
        "nohup_cmd_fixedg_freek = f\"\"\"cd /Users/sarahurbut/aladynoulli2/claudefile && nohup python run_aladyn_predict_with_master_vector_cenosrE_fixedg_freek.py \\\\\n",
        "    --trained_model_path {master_path} \\\\\n",
        "    --pooled_gamma_path {pooled_gk_path} \\\\\n",
        "    --output_dir {output_dir_fixedg_freek} \\\\\n",
        "    --max_batches 5 \\\\\n",
        "    --num_epochs 200 \\\\\n",
        "    --learning_rate 1e-1 \\\\\n",
        "    --lambda_reg 1e-2 \\\\\n",
        "    > predict_fixedg_freek.log 2>&1 &\"\"\"\n",
        "print(nohup_cmd_fixedg_freek)\n",
        "print()\n",
        "print(\"=\"*80)"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "## 2. Run Fixed Kappa, Free Gamma (5 batches)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {},
      "outputs": [],
      "source": [
        "# Fixed kappa, free gamma - NOHUP COMMAND\n",
        "script_fixedk_freeg = base_dir / 'run_aladyn_predict_with_master_vector_cenosrE_fixedk_freeg.py'\n",
        "output_dir_fixedk_freeg = '/Users/sarahurbut/Library/CloudStorage/Dropbox/enrollment_predictions_fixedphi_fixedk_freeg_vectorized/'\n",
        "\n",
        "print(\"=\"*80)\n",
        "print(\"NOHUP COMMAND: Fixed Kappa, Free Gamma (5 batches)\")\n",
        "print(\"=\"*80)\n",
        "print(\"Run this in terminal:\")\n",
        "print()\n",
        "nohup_cmd_fixedk_freeg = f\"\"\"cd /Users/sarahurbut/aladynoulli2/claudefile && nohup python run_aladyn_predict_with_master_vector_cenosrE_fixedk_freeg.py \\\\\n",
        "    --trained_model_path {master_path} \\\\\n",
        "    --pooled_kappa_path {pooled_gk_path} \\\\\n",
        "    --output_dir {output_dir_fixedk_freeg} \\\\\n",
        "    --max_batches 5 \\\\\n",
        "    --num_epochs 200 \\\\\n",
        "    --learning_rate 1e-1 \\\\\n",
        "    --lambda_reg 1e-2 \\\\\n",
        "    > predict_fixedk_freeg.log 2>&1 &\"\"\"\n",
        "print(nohup_cmd_fixedk_freeg)\n",
        "print()\n",
        "print(\"=\"*80)"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "## 3. Compare AUCs Across All Configurations\n",
        "\n",
        "After running the above, we'll compare AUCs for the first 5 batches across:\n",
        "- Original (gamma free, kappa free)\n",
        "- Fixed gamma, free kappa\n",
        "- Fixed kappa, free gamma\n",
        "- Fixed both (gamma fixed, kappa fixed)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {},
      "outputs": [],
      "source": [
        "# TODO: Create comparison script after predictions are done\n",
        "print(\"After running predictions, we'll compare AUCs using:\")\n",
        "print(\"  - Original: enrollment_predictions_fixedphi_correctedE_vectorized\")\n",
        "print(\"  - Fixed gamma, free kappa: enrollment_predictions_fixedphi_fixedg_freek_vectorized\")\n",
        "print(\"  - Fixed kappa, free gamma: enrollment_predictions_fixedphi_fixedk_freeg_vectorized\")\n",
        "print(\"  - Fixed both: enrollment_predictions_fixedphi_fixedgk_vectorized\")\n",
        "print()\n",
        "print(\"We can use compare_fixedgk_vs_original_auc.py as a template.\")"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 1,
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "================================================================================\n",
            "EVALUATING ALL 4 CONFIGURATIONS - FIRST 5 BATCHES (50K PATIENTS)\n",
            "================================================================================\n",
            "Batch size: 10000\n",
            "Number of batches: 5\n",
            "Total patients: 50,000\n",
            "Bootstrap iterations: 100\n",
            "================================================================================\n",
            "\n",
            "Loading data files...\n",
            "✓ Loaded Y: torch.Size([50000, 348, 52]), E: torch.Size([50000, 348]), pce_df: 50000 rows\n",
            "\n",
            "================================================================================\n",
            "CONFIGURATION: FIXEDK_FREEG\n",
            "Directory: /Users/sarahurbut/Library/CloudStorage/Dropbox/enrollment_predictions_fixedphi_fixedk_freeg_vectorized/\n",
            "================================================================================\n",
            "  Pooling 5 batches from enrollment_predictions_fixedphi_fixedk_freeg_vectorized...\n",
            "    ✓ Batch 0: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 1: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 2: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 3: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 4: torch.Size([10000, 348, 52])\n",
            "  ✓ Pooled shape: torch.Size([50000, 348, 52])\n",
            "\n",
            "================================================================================\n",
            "EVALUATING: FIXEDK_FREEG\n",
            "================================================================================\n",
            "\n",
            "Evaluating static 10-year AUC...\n",
            "\n",
            "Evaluating ASCVD (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.732 (0.725-0.741) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 4333 (8.7%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for ASCVD.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.710, Events = 1446/27107\n",
            "   Male: AUC = 0.714, Events = 2887/22893\n",
            "\n",
            "   ASCVD risk in patients with pre-existing conditions:\n",
            "   RA: AUC = 0.710, Events = 36/248\n",
            "   Breast_Cancer: AUC = 0.658, Events = 48/840\n",
            "\n",
            "Evaluating Diabetes (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.629 (0.618-0.641) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2921 (5.8%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Diabetes.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.623, Events = 1193/27107\n",
            "   Male: AUC = 0.625, Events = 1728/22893\n",
            "\n",
            "Evaluating Atrial_Fib (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.709 (0.698-0.722) (calculated on 49353 individuals)\n",
            "Events (10-Year in Eval Cohort): 1919 (3.8%) (from 50000 individuals)\n",
            "Excluded 647 prevalent cases for Atrial_Fib.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.713, Events = 1041/26933\n",
            "   Male: AUC = 0.712, Events = 852/22420\n",
            "\n",
            "Evaluating CKD (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.703 (0.689-0.716) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 1135 (2.3%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for CKD.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.708, Events = 530/27107\n",
            "   Male: AUC = 0.696, Events = 605/22893\n",
            "\n",
            "Evaluating All_Cancers (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.674 (0.664-0.684) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2521 (5.0%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for All_Cancers.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.640, Events = 785/27107\n",
            "   Male: AUC = 0.676, Events = 1736/22893\n",
            "\n",
            "Evaluating Stroke (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.676 (0.653-0.691) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 692 (1.4%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Stroke.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.673, Events = 313/27107\n",
            "   Male: AUC = 0.674, Events = 379/22893\n",
            "\n",
            "Evaluating Heart_Failure (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.705 (0.689-0.718) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 991 (2.0%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Heart_Failure.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.732, Events = 352/27107\n",
            "   Male: AUC = 0.680, Events = 639/22893\n",
            "\n",
            "Evaluating Pneumonia (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.650 (0.638-0.660) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 1758 (3.5%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Pneumonia.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.650, Events = 773/27107\n",
            "   Male: AUC = 0.644, Events = 985/22893\n",
            "\n",
            "Evaluating COPD (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.665 (0.652-0.678) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2071 (4.1%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for COPD.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.667, Events = 925/27107\n",
            "   Male: AUC = 0.658, Events = 1146/22893\n",
            "\n",
            "Evaluating Osteoporosis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.675 (0.659-0.693) (calculated on 49858 individuals)\n",
            "Events (10-Year in Eval Cohort): 1101 (2.2%) (from 50000 individuals)\n",
            "Excluded 142 prevalent cases for Osteoporosis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.675, Events = 611/26995\n",
            "   Male: AUC = 0.677, Events = 489/22863\n",
            "\n",
            "Evaluating Anemia (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.595 (0.584-0.605) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2676 (5.4%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Anemia.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.568, Events = 1430/27107\n",
            "   Male: AUC = 0.625, Events = 1246/22893\n",
            "\n",
            "Evaluating Colorectal_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.653 (0.631-0.673) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 613 (1.2%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.630, Events = 282/27107\n",
            "   Male: AUC = 0.669, Events = 331/22893\n",
            "\n",
            "Evaluating Breast_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "Filtering for Female: Found 27107 individuals in cohort\n",
            "AUC: 0.548 (0.531-0.563) (calculated on 27107 individuals)\n",
            "Events (10-Year in Eval Cohort): 1098 (4.1%) (from 27107 individuals)\n",
            "Excluded 0 prevalent cases for Breast_Cancer.\n",
            "\n",
            "Evaluating Prostate_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "Filtering for Male: Found 22893 individuals in cohort\n",
            "AUC: 0.681 (0.668-0.694) (calculated on 22640 individuals)\n",
            "Events (10-Year in Eval Cohort): 952 (4.2%) (from 22893 individuals)\n",
            "Excluded 253 prevalent cases for Prostate_Cancer.\n",
            "\n",
            "Evaluating Lung_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.675 (0.655-0.696) (calculated on 49963 individuals)\n",
            "Events (10-Year in Eval Cohort): 432 (0.9%) (from 50000 individuals)\n",
            "Excluded 37 prevalent cases for Lung_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.681, Events = 218/27088\n",
            "   Male: AUC = 0.671, Events = 212/22875\n",
            "\n",
            "Evaluating Bladder_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.716 (0.680-0.748) (calculated on 49870 individuals)\n",
            "Events (10-Year in Eval Cohort): 255 (0.5%) (from 50000 individuals)\n",
            "Excluded 130 prevalent cases for Bladder_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.693, Events = 148/27077\n",
            "   Male: AUC = 0.749, Events = 107/22793\n",
            "\n",
            "Evaluating Secondary_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.607 (0.592-0.619) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 1497 (3.0%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Secondary_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.586, Events = 857/27107\n",
            "   Male: AUC = 0.636, Events = 640/22893\n",
            "\n",
            "Evaluating Depression (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.478 (0.469-0.492) (calculated on 49510 individuals)\n",
            "Events (10-Year in Eval Cohort): 1995 (4.0%) (from 50000 individuals)\n",
            "Excluded 490 prevalent cases for Depression.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.475, Events = 1071/26809\n",
            "   Male: AUC = 0.493, Events = 909/22701\n",
            "\n",
            "Evaluating Anxiety (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.515 (0.501-0.534) (calculated on 49863 individuals)\n",
            "Events (10-Year in Eval Cohort): 1289 (2.6%) (from 50000 individuals)\n",
            "Excluded 137 prevalent cases for Anxiety.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.523, Events = 692/27021\n",
            "   Male: AUC = 0.510, Events = 597/22842\n",
            "\n",
            "Evaluating Bipolar_Disorder (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.451 (0.399-0.511) (calculated on 49925 individuals)\n",
            "Events (10-Year in Eval Cohort): 121 (0.2%) (from 50000 individuals)\n",
            "Excluded 75 prevalent cases for Bipolar_Disorder.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.467, Events = 69/27055\n",
            "   Male: AUC = 0.421, Events = 51/22870\n",
            "\n",
            "Evaluating Rheumatoid_Arthritis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.611 (0.588-0.631) (calculated on 49752 individuals)\n",
            "Events (10-Year in Eval Cohort): 595 (1.2%) (from 50000 individuals)\n",
            "Excluded 248 prevalent cases for Rheumatoid_Arthritis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.617, Events = 314/26913\n",
            "   Male: AUC = 0.608, Events = 279/22839\n",
            "\n",
            "Evaluating Psoriasis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.550 (0.511-0.584) (calculated on 49901 individuals)\n",
            "Events (10-Year in Eval Cohort): 236 (0.5%) (from 50000 individuals)\n",
            "Excluded 99 prevalent cases for Psoriasis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.532, Events = 111/27069\n",
            "   Male: AUC = 0.565, Events = 124/22832\n",
            "\n",
            "Evaluating Ulcerative_Colitis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.572 (0.537-0.608) (calculated on 49750 individuals)\n",
            "Events (10-Year in Eval Cohort): 248 (0.5%) (from 50000 individuals)\n",
            "Excluded 250 prevalent cases for Ulcerative_Colitis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.575, Events = 144/26979\n",
            "   Male: AUC = 0.571, Events = 103/22771\n",
            "\n",
            "Evaluating Crohns_Disease (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.577 (0.518-0.621) (calculated on 49850 individuals)\n",
            "Events (10-Year in Eval Cohort): 136 (0.3%) (from 50000 individuals)\n",
            "Excluded 150 prevalent cases for Crohns_Disease.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.591, Events = 77/27034\n",
            "   Male: AUC = 0.561, Events = 59/22816\n",
            "\n",
            "Evaluating Asthma (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.526 (0.515-0.535) (calculated on 48407 individuals)\n",
            "Events (10-Year in Eval Cohort): 3038 (6.1%) (from 50000 individuals)\n",
            "Excluded 1593 prevalent cases for Asthma.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.544, Events = 1591/26140\n",
            "   Male: AUC = 0.543, Events = 1350/22267\n",
            "\n",
            "Evaluating Parkinsons (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.728 (0.704-0.753) (calculated on 49971 individuals)\n",
            "Events (10-Year in Eval Cohort): 223 (0.4%) (from 50000 individuals)\n",
            "Excluded 29 prevalent cases for Parkinsons.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.740, Events = 124/27095\n",
            "   Male: AUC = 0.714, Events = 99/22876\n",
            "\n",
            "Evaluating Multiple_Sclerosis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.529 (0.451-0.582) (calculated on 49869 individuals)\n",
            "Events (10-Year in Eval Cohort): 97 (0.2%) (from 50000 individuals)\n",
            "Excluded 131 prevalent cases for Multiple_Sclerosis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.521, Events = 61/27009\n",
            "   Male: AUC = 0.544, Events = 36/22860\n",
            "\n",
            "Evaluating Thyroid_Disorders (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.574 (0.563-0.585) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2238 (4.5%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.574, Events = 1792/27107\n",
            "   Male: AUC = 0.561, Events = 446/22893\n",
            "\n",
            "Summary of Results (Prospective 10-Year Outcome, 1-Year Score, Sex-Adjusted):\n",
            "--------------------------------------------------------------------------------\n",
            "Disease Group        AUC                       Events     Rate (%)  \n",
            "--------------------------------------------------------------------------------\n",
            "ASCVD                0.732 (0.725-0.741)       4333       8.7\n",
            "Diabetes             0.629 (0.618-0.641)       2921       5.8\n",
            "Atrial_Fib           0.709 (0.698-0.722)       1919       3.8\n",
            "CKD                  0.703 (0.689-0.716)       1135       2.3\n",
            "All_Cancers          0.674 (0.664-0.684)       2521       5.0\n",
            "Stroke               0.676 (0.653-0.691)       692        1.4\n",
            "Heart_Failure        0.705 (0.689-0.718)       991        2.0\n",
            "Pneumonia            0.650 (0.638-0.660)       1758       3.5\n",
            "COPD                 0.665 (0.652-0.678)       2071       4.1\n",
            "Osteoporosis         0.675 (0.659-0.693)       1101       2.2\n",
            "Anemia               0.595 (0.584-0.605)       2676       5.4\n",
            "Colorectal_Cancer    0.653 (0.631-0.673)       613        1.2\n",
            "Breast_Cancer        0.548 (0.531-0.563)       1098       4.1\n",
            "Prostate_Cancer      0.681 (0.668-0.694)       952        4.2\n",
            "Lung_Cancer          0.675 (0.655-0.696)       432        0.9\n",
            "Bladder_Cancer       0.716 (0.680-0.748)       255        0.5\n",
            "Secondary_Cancer     0.607 (0.592-0.619)       1497       3.0\n",
            "Depression           0.478 (0.469-0.492)       1995       4.0\n",
            "Anxiety              0.515 (0.501-0.534)       1289       2.6\n",
            "Bipolar_Disorder     0.451 (0.399-0.511)       121        0.2\n",
            "Rheumatoid_Arthritis 0.611 (0.588-0.631)       595        1.2\n",
            "Psoriasis            0.550 (0.511-0.584)       236        0.5\n",
            "Ulcerative_Colitis   0.572 (0.537-0.608)       248        0.5\n",
            "Crohns_Disease       0.577 (0.518-0.621)       136        0.3\n",
            "Asthma               0.526 (0.515-0.535)       3038       6.1\n",
            "Parkinsons           0.728 (0.704-0.753)       223        0.4\n",
            "Multiple_Sclerosis   0.529 (0.451-0.582)       97         0.2\n",
            "Thyroid_Disorders    0.574 (0.563-0.585)       2238       4.5\n",
            "--------------------------------------------------------------------------------\n",
            "Evaluating dynamic 1-year AUC...\n",
            "Filtering for 1: Found 22893 individuals in cohort\n",
            "\n",
            "Summary of Results (1-Year Risk, Sex-Adjusted, Offset=0):\n",
            "--------------------------------------------------------------------------------\n",
            "Disease Group        AUC                       Events     Rate (%)   C-index   \n",
            "--------------------------------------------------------------------------------\n",
            "ASCVD                0.873 (0.849-0.893)       397        0.8        N/A\n",
            "Diabetes             0.715 (0.669-0.760)       195        0.4        N/A\n",
            "Atrial_Fib           0.837 (0.800-0.870)       120        0.2        N/A\n",
            "CKD                  0.683 (0.541-0.821)       16         0.0        N/A\n",
            "All_Cancers          0.737 (0.702-0.784)       115        0.2        N/A\n",
            "Stroke               0.659 (0.582-0.730)       30         0.1        N/A\n",
            "Heart_Failure        0.812 (0.756-0.882)       51         0.1        N/A\n",
            "Pneumonia            0.611 (0.544-0.692)       56         0.1        N/A\n",
            "COPD                 0.725 (0.668-0.763)       99         0.2        N/A\n",
            "Osteoporosis         0.786 (0.722-0.848)       44         0.1        N/A\n",
            "Anemia               0.632 (0.590-0.674)       144        0.3        N/A\n",
            "Colorectal_Cancer    0.851 (0.790-0.893)       37         0.1        N/A\n",
            "Breast_Cancer        0.834 (0.794-0.879)       89         0.2        N/A\n",
            "Prostate_Cancer      0.801 (0.757-0.864)       56         0.2        N/A\n",
            "Lung_Cancer          0.745 (0.602-0.871)       11         0.0        N/A\n",
            "Bladder_Cancer       0.824 (0.657-0.972)       9          0.0        N/A\n",
            "Secondary_Cancer     0.599 (0.512-0.676)       51         0.1        N/A\n",
            "Depression           0.669 (0.591-0.744)       62         0.1        N/A\n",
            "Anxiety              0.684 (0.548-0.822)       24         0.0        N/A\n",
            "Bipolar_Disorder     0.734 (0.489-0.994)       4          0.0        N/A\n",
            "Rheumatoid_Arthritis 0.804 (0.713-0.887)       34         0.1        N/A\n",
            "Psoriasis            0.685 (0.537-0.842)       9          0.0        N/A\n",
            "Ulcerative_Colitis   0.935 (0.873-0.984)       17         0.0        N/A\n",
            "Crohns_Disease       0.970 (0.950-0.985)       7          0.0        N/A\n",
            "Asthma               0.666 (0.620-0.713)       251        0.5        N/A\n",
            "Parkinsons           0.769 (0.588-0.906)       10         0.0        N/A\n",
            "Multiple_Sclerosis   0.938 (0.887-0.971)       13         0.0        N/A\n",
            "Thyroid_Disorders    0.658 (0.601-0.703)       137        0.3        N/A\n",
            "--------------------------------------------------------------------------------\n",
            "  ✓ Static 10-year: 28 diseases\n",
            "  ✓ Dynamic 1-year: 28 diseases\n",
            "\n",
            "================================================================================\n",
            "CONFIGURATION: FIXEDG_FREEK\n",
            "Directory: /Users/sarahurbut/Library/CloudStorage/Dropbox/enrollment_predictions_fixedphi_fixedg_freek_vectorized/\n",
            "================================================================================\n",
            "  Pooling 5 batches from enrollment_predictions_fixedphi_fixedg_freek_vectorized...\n",
            "    ✓ Batch 0: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 1: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 2: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 3: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 4: torch.Size([10000, 348, 52])\n",
            "  ✓ Pooled shape: torch.Size([50000, 348, 52])\n",
            "\n",
            "================================================================================\n",
            "EVALUATING: FIXEDG_FREEK\n",
            "================================================================================\n",
            "\n",
            "Evaluating static 10-year AUC...\n",
            "\n",
            "Evaluating ASCVD (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.695 (0.686-0.701) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 4333 (8.7%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for ASCVD.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.692, Events = 1446/27107\n",
            "   Male: AUC = 0.688, Events = 2887/22893\n",
            "\n",
            "   ASCVD risk in patients with pre-existing conditions:\n",
            "   RA: AUC = 0.675, Events = 36/248\n",
            "   Breast_Cancer: AUC = 0.644, Events = 48/840\n",
            "\n",
            "Evaluating Diabetes (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.603 (0.596-0.611) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2921 (5.8%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Diabetes.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.598, Events = 1193/27107\n",
            "   Male: AUC = 0.601, Events = 1728/22893\n",
            "\n",
            "Evaluating Atrial_Fib (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.704 (0.695-0.715) (calculated on 49353 individuals)\n",
            "Events (10-Year in Eval Cohort): 1919 (3.8%) (from 50000 individuals)\n",
            "Excluded 647 prevalent cases for Atrial_Fib.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.708, Events = 1041/26933\n",
            "   Male: AUC = 0.708, Events = 852/22420\n",
            "\n",
            "Evaluating CKD (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.705 (0.691-0.720) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 1135 (2.3%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for CKD.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.709, Events = 530/27107\n",
            "   Male: AUC = 0.697, Events = 605/22893\n",
            "\n",
            "Evaluating All_Cancers (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.669 (0.659-0.681) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2521 (5.0%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for All_Cancers.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.639, Events = 785/27107\n",
            "   Male: AUC = 0.674, Events = 1736/22893\n",
            "\n",
            "Evaluating Stroke (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.675 (0.658-0.695) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 692 (1.4%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Stroke.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.672, Events = 313/27107\n",
            "   Male: AUC = 0.673, Events = 379/22893\n",
            "\n",
            "Evaluating Heart_Failure (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.704 (0.689-0.717) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 991 (2.0%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Heart_Failure.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.732, Events = 352/27107\n",
            "   Male: AUC = 0.680, Events = 639/22893\n",
            "\n",
            "Evaluating Pneumonia (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.649 (0.638-0.664) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 1758 (3.5%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Pneumonia.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.649, Events = 773/27107\n",
            "   Male: AUC = 0.645, Events = 985/22893\n",
            "\n",
            "Evaluating COPD (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.664 (0.651-0.674) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2071 (4.1%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for COPD.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.666, Events = 925/27107\n",
            "   Male: AUC = 0.657, Events = 1146/22893\n",
            "\n",
            "Evaluating Osteoporosis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.669 (0.656-0.687) (calculated on 49858 individuals)\n",
            "Events (10-Year in Eval Cohort): 1101 (2.2%) (from 50000 individuals)\n",
            "Excluded 142 prevalent cases for Osteoporosis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.669, Events = 611/26995\n",
            "   Male: AUC = 0.670, Events = 489/22863\n",
            "\n",
            "Evaluating Anemia (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.595 (0.586-0.608) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2676 (5.4%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Anemia.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.567, Events = 1430/27107\n",
            "   Male: AUC = 0.626, Events = 1246/22893\n",
            "\n",
            "Evaluating Colorectal_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.647 (0.628-0.669) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 613 (1.2%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.624, Events = 282/27107\n",
            "   Male: AUC = 0.663, Events = 331/22893\n",
            "\n",
            "Evaluating Breast_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "Filtering for Female: Found 27107 individuals in cohort\n",
            "AUC: 0.542 (0.526-0.560) (calculated on 27107 individuals)\n",
            "Events (10-Year in Eval Cohort): 1098 (4.1%) (from 27107 individuals)\n",
            "Excluded 0 prevalent cases for Breast_Cancer.\n",
            "\n",
            "Evaluating Prostate_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "Filtering for Male: Found 22893 individuals in cohort\n",
            "AUC: 0.678 (0.662-0.691) (calculated on 22640 individuals)\n",
            "Events (10-Year in Eval Cohort): 952 (4.2%) (from 22893 individuals)\n",
            "Excluded 253 prevalent cases for Prostate_Cancer.\n",
            "\n",
            "Evaluating Lung_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.673 (0.652-0.697) (calculated on 49963 individuals)\n",
            "Events (10-Year in Eval Cohort): 432 (0.9%) (from 50000 individuals)\n",
            "Excluded 37 prevalent cases for Lung_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.679, Events = 218/27088\n",
            "   Male: AUC = 0.671, Events = 212/22875\n",
            "\n",
            "Evaluating Bladder_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.704 (0.676-0.739) (calculated on 49870 individuals)\n",
            "Events (10-Year in Eval Cohort): 255 (0.5%) (from 50000 individuals)\n",
            "Excluded 130 prevalent cases for Bladder_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.680, Events = 148/27077\n",
            "   Male: AUC = 0.738, Events = 107/22793\n",
            "\n",
            "Evaluating Secondary_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.605 (0.593-0.615) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 1497 (3.0%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Secondary_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.583, Events = 857/27107\n",
            "   Male: AUC = 0.635, Events = 640/22893\n",
            "\n",
            "Evaluating Depression (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.471 (0.457-0.484) (calculated on 49510 individuals)\n",
            "Events (10-Year in Eval Cohort): 1995 (4.0%) (from 50000 individuals)\n",
            "Excluded 490 prevalent cases for Depression.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.467, Events = 1071/26809\n",
            "   Male: AUC = 0.486, Events = 909/22701\n",
            "\n",
            "Evaluating Anxiety (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.509 (0.492-0.523) (calculated on 49863 individuals)\n",
            "Events (10-Year in Eval Cohort): 1289 (2.6%) (from 50000 individuals)\n",
            "Excluded 137 prevalent cases for Anxiety.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.518, Events = 692/27021\n",
            "   Male: AUC = 0.502, Events = 597/22842\n",
            "\n",
            "Evaluating Bipolar_Disorder (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.452 (0.390-0.500) (calculated on 49925 individuals)\n",
            "Events (10-Year in Eval Cohort): 121 (0.2%) (from 50000 individuals)\n",
            "Excluded 75 prevalent cases for Bipolar_Disorder.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.477, Events = 69/27055\n",
            "   Male: AUC = 0.409, Events = 51/22870\n",
            "\n",
            "Evaluating Rheumatoid_Arthritis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.606 (0.586-0.627) (calculated on 49752 individuals)\n",
            "Events (10-Year in Eval Cohort): 595 (1.2%) (from 50000 individuals)\n",
            "Excluded 248 prevalent cases for Rheumatoid_Arthritis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.608, Events = 314/26913\n",
            "   Male: AUC = 0.606, Events = 279/22839\n",
            "\n",
            "Evaluating Psoriasis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.549 (0.514-0.587) (calculated on 49901 individuals)\n",
            "Events (10-Year in Eval Cohort): 236 (0.5%) (from 50000 individuals)\n",
            "Excluded 99 prevalent cases for Psoriasis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.537, Events = 111/27069\n",
            "   Male: AUC = 0.558, Events = 124/22832\n",
            "\n",
            "Evaluating Ulcerative_Colitis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.568 (0.541-0.603) (calculated on 49750 individuals)\n",
            "Events (10-Year in Eval Cohort): 248 (0.5%) (from 50000 individuals)\n",
            "Excluded 250 prevalent cases for Ulcerative_Colitis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.570, Events = 144/26979\n",
            "   Male: AUC = 0.569, Events = 103/22771\n",
            "\n",
            "Evaluating Crohns_Disease (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.557 (0.503-0.618) (calculated on 49850 individuals)\n",
            "Events (10-Year in Eval Cohort): 136 (0.3%) (from 50000 individuals)\n",
            "Excluded 150 prevalent cases for Crohns_Disease.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.574, Events = 77/27034\n",
            "   Male: AUC = 0.538, Events = 59/22816\n",
            "\n",
            "Evaluating Asthma (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.519 (0.507-0.531) (calculated on 48407 individuals)\n",
            "Events (10-Year in Eval Cohort): 3038 (6.1%) (from 50000 individuals)\n",
            "Excluded 1593 prevalent cases for Asthma.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.538, Events = 1591/26140\n",
            "   Male: AUC = 0.535, Events = 1350/22267\n",
            "\n",
            "Evaluating Parkinsons (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.731 (0.710-0.756) (calculated on 49971 individuals)\n",
            "Events (10-Year in Eval Cohort): 223 (0.4%) (from 50000 individuals)\n",
            "Excluded 29 prevalent cases for Parkinsons.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.744, Events = 124/27095\n",
            "   Male: AUC = 0.715, Events = 99/22876\n",
            "\n",
            "Evaluating Multiple_Sclerosis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.542 (0.472-0.608) (calculated on 49869 individuals)\n",
            "Events (10-Year in Eval Cohort): 97 (0.2%) (from 50000 individuals)\n",
            "Excluded 131 prevalent cases for Multiple_Sclerosis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.523, Events = 61/27009\n",
            "   Male: AUC = 0.577, Events = 36/22860\n",
            "\n",
            "Evaluating Thyroid_Disorders (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.563 (0.550-0.574) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2238 (4.5%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.572, Events = 1792/27107\n",
            "   Male: AUC = 0.557, Events = 446/22893\n",
            "\n",
            "Summary of Results (Prospective 10-Year Outcome, 1-Year Score, Sex-Adjusted):\n",
            "--------------------------------------------------------------------------------\n",
            "Disease Group        AUC                       Events     Rate (%)  \n",
            "--------------------------------------------------------------------------------\n",
            "ASCVD                0.695 (0.686-0.701)       4333       8.7\n",
            "Diabetes             0.603 (0.596-0.611)       2921       5.8\n",
            "Atrial_Fib           0.704 (0.695-0.715)       1919       3.8\n",
            "CKD                  0.705 (0.691-0.720)       1135       2.3\n",
            "All_Cancers          0.669 (0.659-0.681)       2521       5.0\n",
            "Stroke               0.675 (0.658-0.695)       692        1.4\n",
            "Heart_Failure        0.704 (0.689-0.717)       991        2.0\n",
            "Pneumonia            0.649 (0.638-0.664)       1758       3.5\n",
            "COPD                 0.664 (0.651-0.674)       2071       4.1\n",
            "Osteoporosis         0.669 (0.656-0.687)       1101       2.2\n",
            "Anemia               0.595 (0.586-0.608)       2676       5.4\n",
            "Colorectal_Cancer    0.647 (0.628-0.669)       613        1.2\n",
            "Breast_Cancer        0.542 (0.526-0.560)       1098       4.1\n",
            "Prostate_Cancer      0.678 (0.662-0.691)       952        4.2\n",
            "Lung_Cancer          0.673 (0.652-0.697)       432        0.9\n",
            "Bladder_Cancer       0.704 (0.676-0.739)       255        0.5\n",
            "Secondary_Cancer     0.605 (0.593-0.615)       1497       3.0\n",
            "Depression           0.471 (0.457-0.484)       1995       4.0\n",
            "Anxiety              0.509 (0.492-0.523)       1289       2.6\n",
            "Bipolar_Disorder     0.452 (0.390-0.500)       121        0.2\n",
            "Rheumatoid_Arthritis 0.606 (0.586-0.627)       595        1.2\n",
            "Psoriasis            0.549 (0.514-0.587)       236        0.5\n",
            "Ulcerative_Colitis   0.568 (0.541-0.603)       248        0.5\n",
            "Crohns_Disease       0.557 (0.503-0.618)       136        0.3\n",
            "Asthma               0.519 (0.507-0.531)       3038       6.1\n",
            "Parkinsons           0.731 (0.710-0.756)       223        0.4\n",
            "Multiple_Sclerosis   0.542 (0.472-0.608)       97         0.2\n",
            "Thyroid_Disorders    0.563 (0.550-0.574)       2238       4.5\n",
            "--------------------------------------------------------------------------------\n",
            "Evaluating dynamic 1-year AUC...\n",
            "Filtering for 1: Found 22893 individuals in cohort\n",
            "\n",
            "Summary of Results (1-Year Risk, Sex-Adjusted, Offset=0):\n",
            "--------------------------------------------------------------------------------\n",
            "Disease Group        AUC                       Events     Rate (%)   C-index   \n",
            "--------------------------------------------------------------------------------\n",
            "ASCVD                0.870 (0.847-0.890)       397        0.8        N/A\n",
            "Diabetes             0.685 (0.629-0.733)       195        0.4        N/A\n",
            "Atrial_Fib           0.828 (0.788-0.863)       120        0.2        N/A\n",
            "CKD                  0.680 (0.497-0.827)       16         0.0        N/A\n",
            "All_Cancers          0.731 (0.694-0.768)       115        0.2        N/A\n",
            "Stroke               0.657 (0.591-0.724)       30         0.1        N/A\n",
            "Heart_Failure        0.803 (0.744-0.866)       51         0.1        N/A\n",
            "Pneumonia            0.609 (0.549-0.701)       56         0.1        N/A\n",
            "COPD                 0.726 (0.677-0.777)       99         0.2        N/A\n",
            "Osteoporosis         0.782 (0.703-0.832)       44         0.1        N/A\n",
            "Anemia               0.636 (0.586-0.683)       144        0.3        N/A\n",
            "Colorectal_Cancer    0.851 (0.780-0.909)       37         0.1        N/A\n",
            "Breast_Cancer        0.840 (0.772-0.891)       89         0.2        N/A\n",
            "Prostate_Cancer      0.799 (0.750-0.856)       56         0.2        N/A\n",
            "Lung_Cancer          0.747 (0.598-0.856)       11         0.0        N/A\n",
            "Bladder_Cancer       0.825 (0.550-0.995)       9          0.0        N/A\n",
            "Secondary_Cancer     0.598 (0.527-0.685)       51         0.1        N/A\n",
            "Depression           0.664 (0.573-0.739)       62         0.1        N/A\n",
            "Anxiety              0.679 (0.520-0.807)       24         0.0        N/A\n",
            "Bipolar_Disorder     0.847 (0.708-0.991)       4          0.0        N/A\n",
            "Rheumatoid_Arthritis 0.799 (0.699-0.881)       34         0.1        N/A\n",
            "Psoriasis            0.720 (0.591-0.857)       9          0.0        N/A\n",
            "Ulcerative_Colitis   0.946 (0.891-0.982)       17         0.0        N/A\n",
            "Crohns_Disease       0.965 (0.946-0.982)       7          0.0        N/A\n",
            "Asthma               0.663 (0.626-0.698)       251        0.5        N/A\n",
            "Parkinsons           0.782 (0.555-0.922)       10         0.0        N/A\n",
            "Multiple_Sclerosis   0.947 (0.921-0.967)       13         0.0        N/A\n",
            "Thyroid_Disorders    0.652 (0.597-0.705)       137        0.3        N/A\n",
            "--------------------------------------------------------------------------------\n",
            "  ✓ Static 10-year: 28 diseases\n",
            "  ✓ Dynamic 1-year: 28 diseases\n",
            "\n",
            "================================================================================\n",
            "CONFIGURATION: ORIGINAL\n",
            "Directory: /Users/sarahurbut/Library/CloudStorage/Dropbox/enrollment_predictions_fixedphi_correctedE_vectorized/\n",
            "================================================================================\n",
            "  Pooling 5 batches from enrollment_predictions_fixedphi_correctedE_vectorized...\n",
            "    ✓ Batch 0: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 1: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 2: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 3: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 4: torch.Size([10000, 348, 52])\n",
            "  ✓ Pooled shape: torch.Size([50000, 348, 52])\n",
            "\n",
            "================================================================================\n",
            "EVALUATING: ORIGINAL\n",
            "================================================================================\n",
            "\n",
            "Evaluating static 10-year AUC...\n",
            "\n",
            "Evaluating ASCVD (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.732 (0.726-0.740) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 4333 (8.7%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for ASCVD.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.710, Events = 1446/27107\n",
            "   Male: AUC = 0.714, Events = 2887/22893\n",
            "\n",
            "   ASCVD risk in patients with pre-existing conditions:\n",
            "   RA: AUC = 0.710, Events = 36/248\n",
            "   Breast_Cancer: AUC = 0.657, Events = 48/840\n",
            "\n",
            "Evaluating Diabetes (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.629 (0.617-0.640) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2921 (5.8%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Diabetes.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.624, Events = 1193/27107\n",
            "   Male: AUC = 0.624, Events = 1728/22893\n",
            "\n",
            "Evaluating Atrial_Fib (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.709 (0.699-0.722) (calculated on 49353 individuals)\n",
            "Events (10-Year in Eval Cohort): 1919 (3.8%) (from 50000 individuals)\n",
            "Excluded 647 prevalent cases for Atrial_Fib.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.713, Events = 1041/26933\n",
            "   Male: AUC = 0.712, Events = 852/22420\n",
            "\n",
            "Evaluating CKD (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.703 (0.686-0.715) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 1135 (2.3%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for CKD.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.708, Events = 530/27107\n",
            "   Male: AUC = 0.696, Events = 605/22893\n",
            "\n",
            "Evaluating All_Cancers (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.674 (0.666-0.684) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2521 (5.0%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for All_Cancers.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.640, Events = 785/27107\n",
            "   Male: AUC = 0.676, Events = 1736/22893\n",
            "\n",
            "Evaluating Stroke (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.676 (0.657-0.694) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 692 (1.4%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Stroke.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.673, Events = 313/27107\n",
            "   Male: AUC = 0.673, Events = 379/22893\n",
            "\n",
            "Evaluating Heart_Failure (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.706 (0.692-0.720) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 991 (2.0%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Heart_Failure.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.732, Events = 352/27107\n",
            "   Male: AUC = 0.681, Events = 639/22893\n",
            "\n",
            "Evaluating Pneumonia (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.650 (0.639-0.662) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 1758 (3.5%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Pneumonia.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.651, Events = 773/27107\n",
            "   Male: AUC = 0.644, Events = 985/22893\n",
            "\n",
            "Evaluating COPD (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.665 (0.656-0.675) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2071 (4.1%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for COPD.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.667, Events = 925/27107\n",
            "   Male: AUC = 0.659, Events = 1146/22893\n",
            "\n",
            "Evaluating Osteoporosis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.675 (0.660-0.689) (calculated on 49858 individuals)\n",
            "Events (10-Year in Eval Cohort): 1101 (2.2%) (from 50000 individuals)\n",
            "Excluded 142 prevalent cases for Osteoporosis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.675, Events = 611/26995\n",
            "   Male: AUC = 0.677, Events = 489/22863\n",
            "\n",
            "Evaluating Anemia (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.595 (0.583-0.605) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2676 (5.4%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Anemia.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.568, Events = 1430/27107\n",
            "   Male: AUC = 0.625, Events = 1246/22893\n",
            "\n",
            "Evaluating Colorectal_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.653 (0.633-0.678) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 613 (1.2%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.629, Events = 282/27107\n",
            "   Male: AUC = 0.669, Events = 331/22893\n",
            "\n",
            "Evaluating Breast_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "Filtering for Female: Found 27107 individuals in cohort\n",
            "AUC: 0.548 (0.533-0.565) (calculated on 27107 individuals)\n",
            "Events (10-Year in Eval Cohort): 1098 (4.1%) (from 27107 individuals)\n",
            "Excluded 0 prevalent cases for Breast_Cancer.\n",
            "\n",
            "Evaluating Prostate_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "Filtering for Male: Found 22893 individuals in cohort\n",
            "AUC: 0.681 (0.661-0.694) (calculated on 22640 individuals)\n",
            "Events (10-Year in Eval Cohort): 952 (4.2%) (from 22893 individuals)\n",
            "Excluded 253 prevalent cases for Prostate_Cancer.\n",
            "\n",
            "Evaluating Lung_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.675 (0.657-0.698) (calculated on 49963 individuals)\n",
            "Events (10-Year in Eval Cohort): 432 (0.9%) (from 50000 individuals)\n",
            "Excluded 37 prevalent cases for Lung_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.681, Events = 218/27088\n",
            "   Male: AUC = 0.671, Events = 212/22875\n",
            "\n",
            "Evaluating Bladder_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.716 (0.691-0.743) (calculated on 49870 individuals)\n",
            "Events (10-Year in Eval Cohort): 255 (0.5%) (from 50000 individuals)\n",
            "Excluded 130 prevalent cases for Bladder_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.693, Events = 148/27077\n",
            "   Male: AUC = 0.748, Events = 107/22793\n",
            "\n",
            "Evaluating Secondary_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.607 (0.593-0.621) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 1497 (3.0%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Secondary_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.586, Events = 857/27107\n",
            "   Male: AUC = 0.636, Events = 640/22893\n",
            "\n",
            "Evaluating Depression (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.478 (0.465-0.489) (calculated on 49510 individuals)\n",
            "Events (10-Year in Eval Cohort): 1995 (4.0%) (from 50000 individuals)\n",
            "Excluded 490 prevalent cases for Depression.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.475, Events = 1071/26809\n",
            "   Male: AUC = 0.493, Events = 909/22701\n",
            "\n",
            "Evaluating Anxiety (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.515 (0.500-0.531) (calculated on 49863 individuals)\n",
            "Events (10-Year in Eval Cohort): 1289 (2.6%) (from 50000 individuals)\n",
            "Excluded 137 prevalent cases for Anxiety.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.523, Events = 692/27021\n",
            "   Male: AUC = 0.510, Events = 597/22842\n",
            "\n",
            "Evaluating Bipolar_Disorder (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.449 (0.397-0.505) (calculated on 49925 individuals)\n",
            "Events (10-Year in Eval Cohort): 121 (0.2%) (from 50000 individuals)\n",
            "Excluded 75 prevalent cases for Bipolar_Disorder.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.464, Events = 69/27055\n",
            "   Male: AUC = 0.420, Events = 51/22870\n",
            "\n",
            "Evaluating Rheumatoid_Arthritis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.612 (0.590-0.633) (calculated on 49752 individuals)\n",
            "Events (10-Year in Eval Cohort): 595 (1.2%) (from 50000 individuals)\n",
            "Excluded 248 prevalent cases for Rheumatoid_Arthritis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.617, Events = 314/26913\n",
            "   Male: AUC = 0.609, Events = 279/22839\n",
            "\n",
            "Evaluating Psoriasis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.550 (0.514-0.585) (calculated on 49901 individuals)\n",
            "Events (10-Year in Eval Cohort): 236 (0.5%) (from 50000 individuals)\n",
            "Excluded 99 prevalent cases for Psoriasis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.532, Events = 111/27069\n",
            "   Male: AUC = 0.565, Events = 124/22832\n",
            "\n",
            "Evaluating Ulcerative_Colitis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.572 (0.533-0.604) (calculated on 49750 individuals)\n",
            "Events (10-Year in Eval Cohort): 248 (0.5%) (from 50000 individuals)\n",
            "Excluded 250 prevalent cases for Ulcerative_Colitis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.576, Events = 144/26979\n",
            "   Male: AUC = 0.570, Events = 103/22771\n",
            "\n",
            "Evaluating Crohns_Disease (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.578 (0.533-0.626) (calculated on 49850 individuals)\n",
            "Events (10-Year in Eval Cohort): 136 (0.3%) (from 50000 individuals)\n",
            "Excluded 150 prevalent cases for Crohns_Disease.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.593, Events = 77/27034\n",
            "   Male: AUC = 0.562, Events = 59/22816\n",
            "\n",
            "Evaluating Asthma (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.526 (0.518-0.536) (calculated on 48407 individuals)\n",
            "Events (10-Year in Eval Cohort): 3038 (6.1%) (from 50000 individuals)\n",
            "Excluded 1593 prevalent cases for Asthma.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.544, Events = 1591/26140\n",
            "   Male: AUC = 0.543, Events = 1350/22267\n",
            "\n",
            "Evaluating Parkinsons (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.728 (0.702-0.752) (calculated on 49971 individuals)\n",
            "Events (10-Year in Eval Cohort): 223 (0.4%) (from 50000 individuals)\n",
            "Excluded 29 prevalent cases for Parkinsons.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.740, Events = 124/27095\n",
            "   Male: AUC = 0.713, Events = 99/22876\n",
            "\n",
            "Evaluating Multiple_Sclerosis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.525 (0.454-0.582) (calculated on 49869 individuals)\n",
            "Events (10-Year in Eval Cohort): 97 (0.2%) (from 50000 individuals)\n",
            "Excluded 131 prevalent cases for Multiple_Sclerosis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.517, Events = 61/27009\n",
            "   Male: AUC = 0.542, Events = 36/22860\n",
            "\n",
            "Evaluating Thyroid_Disorders (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.574 (0.563-0.585) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2238 (4.5%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.574, Events = 1792/27107\n",
            "   Male: AUC = 0.561, Events = 446/22893\n",
            "\n",
            "Summary of Results (Prospective 10-Year Outcome, 1-Year Score, Sex-Adjusted):\n",
            "--------------------------------------------------------------------------------\n",
            "Disease Group        AUC                       Events     Rate (%)  \n",
            "--------------------------------------------------------------------------------\n",
            "ASCVD                0.732 (0.726-0.740)       4333       8.7\n",
            "Diabetes             0.629 (0.617-0.640)       2921       5.8\n",
            "Atrial_Fib           0.709 (0.699-0.722)       1919       3.8\n",
            "CKD                  0.703 (0.686-0.715)       1135       2.3\n",
            "All_Cancers          0.674 (0.666-0.684)       2521       5.0\n",
            "Stroke               0.676 (0.657-0.694)       692        1.4\n",
            "Heart_Failure        0.706 (0.692-0.720)       991        2.0\n",
            "Pneumonia            0.650 (0.639-0.662)       1758       3.5\n",
            "COPD                 0.665 (0.656-0.675)       2071       4.1\n",
            "Osteoporosis         0.675 (0.660-0.689)       1101       2.2\n",
            "Anemia               0.595 (0.583-0.605)       2676       5.4\n",
            "Colorectal_Cancer    0.653 (0.633-0.678)       613        1.2\n",
            "Breast_Cancer        0.548 (0.533-0.565)       1098       4.1\n",
            "Prostate_Cancer      0.681 (0.661-0.694)       952        4.2\n",
            "Lung_Cancer          0.675 (0.657-0.698)       432        0.9\n",
            "Bladder_Cancer       0.716 (0.691-0.743)       255        0.5\n",
            "Secondary_Cancer     0.607 (0.593-0.621)       1497       3.0\n",
            "Depression           0.478 (0.465-0.489)       1995       4.0\n",
            "Anxiety              0.515 (0.500-0.531)       1289       2.6\n",
            "Bipolar_Disorder     0.449 (0.397-0.505)       121        0.2\n",
            "Rheumatoid_Arthritis 0.612 (0.590-0.633)       595        1.2\n",
            "Psoriasis            0.550 (0.514-0.585)       236        0.5\n",
            "Ulcerative_Colitis   0.572 (0.533-0.604)       248        0.5\n",
            "Crohns_Disease       0.578 (0.533-0.626)       136        0.3\n",
            "Asthma               0.526 (0.518-0.536)       3038       6.1\n",
            "Parkinsons           0.728 (0.702-0.752)       223        0.4\n",
            "Multiple_Sclerosis   0.525 (0.454-0.582)       97         0.2\n",
            "Thyroid_Disorders    0.574 (0.563-0.585)       2238       4.5\n",
            "--------------------------------------------------------------------------------\n",
            "Evaluating dynamic 1-year AUC...\n",
            "Filtering for 1: Found 22893 individuals in cohort\n",
            "\n",
            "Summary of Results (1-Year Risk, Sex-Adjusted, Offset=0):\n",
            "--------------------------------------------------------------------------------\n",
            "Disease Group        AUC                       Events     Rate (%)   C-index   \n",
            "--------------------------------------------------------------------------------\n",
            "ASCVD                0.873 (0.849-0.896)       397        0.8        N/A\n",
            "Diabetes             0.714 (0.675-0.750)       195        0.4        N/A\n",
            "Atrial_Fib           0.838 (0.793-0.874)       120        0.2        N/A\n",
            "CKD                  0.684 (0.542-0.825)       16         0.0        N/A\n",
            "All_Cancers          0.737 (0.696-0.784)       115        0.2        N/A\n",
            "Stroke               0.658 (0.578-0.720)       30         0.1        N/A\n",
            "Heart_Failure        0.812 (0.755-0.891)       51         0.1        N/A\n",
            "Pneumonia            0.611 (0.521-0.686)       56         0.1        N/A\n",
            "COPD                 0.724 (0.681-0.785)       99         0.2        N/A\n",
            "Osteoporosis         0.786 (0.721-0.844)       44         0.1        N/A\n",
            "Anemia               0.633 (0.582-0.678)       144        0.3        N/A\n",
            "Colorectal_Cancer    0.852 (0.797-0.918)       37         0.1        N/A\n",
            "Breast_Cancer        0.833 (0.774-0.880)       89         0.2        N/A\n",
            "Prostate_Cancer      0.801 (0.751-0.858)       56         0.2        N/A\n",
            "Lung_Cancer          0.744 (0.624-0.862)       11         0.0        N/A\n",
            "Bladder_Cancer       0.822 (0.693-0.981)       9          0.0        N/A\n",
            "Secondary_Cancer     0.598 (0.522-0.679)       51         0.1        N/A\n",
            "Depression           0.668 (0.586-0.740)       62         0.1        N/A\n",
            "Anxiety              0.682 (0.545-0.822)       24         0.0        N/A\n",
            "Bipolar_Disorder     0.715 (0.343-0.994)       4          0.0        N/A\n",
            "Rheumatoid_Arthritis 0.803 (0.711-0.886)       34         0.1        N/A\n",
            "Psoriasis            0.683 (0.502-0.820)       9          0.0        N/A\n",
            "Ulcerative_Colitis   0.937 (0.875-0.985)       17         0.0        N/A\n",
            "Crohns_Disease       0.970 (0.950-0.985)       7          0.0        N/A\n",
            "Asthma               0.666 (0.626-0.705)       251        0.5        N/A\n",
            "Parkinsons           0.767 (0.623-0.915)       10         0.0        N/A\n",
            "Multiple_Sclerosis   0.935 (0.888-0.975)       13         0.0        N/A\n",
            "Thyroid_Disorders    0.658 (0.616-0.704)       137        0.3        N/A\n",
            "--------------------------------------------------------------------------------\n",
            "  ✓ Static 10-year: 28 diseases\n",
            "  ✓ Dynamic 1-year: 28 diseases\n",
            "\n",
            "================================================================================\n",
            "CONFIGURATION: FIXEDGK\n",
            "Directory: /Users/sarahurbut/Library/CloudStorage/Dropbox/enrollment_predictions_fixedphi_fixedgk_vectorized/\n",
            "================================================================================\n",
            "  Pooling 5 batches from enrollment_predictions_fixedphi_fixedgk_vectorized...\n",
            "    ✓ Batch 0: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 1: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 2: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 3: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 4: torch.Size([10000, 348, 52])\n",
            "  ✓ Pooled shape: torch.Size([50000, 348, 52])\n",
            "\n",
            "================================================================================\n",
            "EVALUATING: FIXEDGK\n",
            "================================================================================\n",
            "\n",
            "Evaluating static 10-year AUC...\n",
            "\n",
            "Evaluating ASCVD (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.695 (0.686-0.702) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 4333 (8.7%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for ASCVD.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.692, Events = 1446/27107\n",
            "   Male: AUC = 0.688, Events = 2887/22893\n",
            "\n",
            "   ASCVD risk in patients with pre-existing conditions:\n",
            "   RA: AUC = 0.676, Events = 36/248\n",
            "   Breast_Cancer: AUC = 0.643, Events = 48/840\n",
            "\n",
            "Evaluating Diabetes (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.603 (0.591-0.612) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2921 (5.8%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Diabetes.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.598, Events = 1193/27107\n",
            "   Male: AUC = 0.601, Events = 1728/22893\n",
            "\n",
            "Evaluating Atrial_Fib (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.704 (0.694-0.714) (calculated on 49353 individuals)\n",
            "Events (10-Year in Eval Cohort): 1919 (3.8%) (from 50000 individuals)\n",
            "Excluded 647 prevalent cases for Atrial_Fib.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.708, Events = 1041/26933\n",
            "   Male: AUC = 0.708, Events = 852/22420\n",
            "\n",
            "Evaluating CKD (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.704 (0.689-0.718) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 1135 (2.3%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for CKD.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.709, Events = 530/27107\n",
            "   Male: AUC = 0.697, Events = 605/22893\n",
            "\n",
            "Evaluating All_Cancers (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.669 (0.660-0.681) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2521 (5.0%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for All_Cancers.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.639, Events = 785/27107\n",
            "   Male: AUC = 0.675, Events = 1736/22893\n",
            "\n",
            "Evaluating Stroke (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.675 (0.653-0.695) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 692 (1.4%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Stroke.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.672, Events = 313/27107\n",
            "   Male: AUC = 0.673, Events = 379/22893\n",
            "\n",
            "Evaluating Heart_Failure (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.704 (0.688-0.717) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 991 (2.0%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Heart_Failure.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.732, Events = 352/27107\n",
            "   Male: AUC = 0.680, Events = 639/22893\n",
            "\n",
            "Evaluating Pneumonia (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.649 (0.638-0.662) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 1758 (3.5%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Pneumonia.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.649, Events = 773/27107\n",
            "   Male: AUC = 0.645, Events = 985/22893\n",
            "\n",
            "Evaluating COPD (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.663 (0.653-0.674) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2071 (4.1%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for COPD.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.666, Events = 925/27107\n",
            "   Male: AUC = 0.657, Events = 1146/22893\n",
            "\n",
            "Evaluating Osteoporosis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.669 (0.655-0.680) (calculated on 49858 individuals)\n",
            "Events (10-Year in Eval Cohort): 1101 (2.2%) (from 50000 individuals)\n",
            "Excluded 142 prevalent cases for Osteoporosis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.669, Events = 611/26995\n",
            "   Male: AUC = 0.670, Events = 489/22863\n",
            "\n",
            "Evaluating Anemia (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.595 (0.583-0.606) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2676 (5.4%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Anemia.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.567, Events = 1430/27107\n",
            "   Male: AUC = 0.626, Events = 1246/22893\n",
            "\n",
            "Evaluating Colorectal_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.647 (0.624-0.669) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 613 (1.2%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.624, Events = 282/27107\n",
            "   Male: AUC = 0.663, Events = 331/22893\n",
            "\n",
            "Evaluating Breast_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "Filtering for Female: Found 27107 individuals in cohort\n",
            "AUC: 0.541 (0.522-0.556) (calculated on 27107 individuals)\n",
            "Events (10-Year in Eval Cohort): 1098 (4.1%) (from 27107 individuals)\n",
            "Excluded 0 prevalent cases for Breast_Cancer.\n",
            "\n",
            "Evaluating Prostate_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "Filtering for Male: Found 22893 individuals in cohort\n",
            "AUC: 0.678 (0.664-0.690) (calculated on 22640 individuals)\n",
            "Events (10-Year in Eval Cohort): 952 (4.2%) (from 22893 individuals)\n",
            "Excluded 253 prevalent cases for Prostate_Cancer.\n",
            "\n",
            "Evaluating Lung_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.673 (0.651-0.697) (calculated on 49963 individuals)\n",
            "Events (10-Year in Eval Cohort): 432 (0.9%) (from 50000 individuals)\n",
            "Excluded 37 prevalent cases for Lung_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.679, Events = 218/27088\n",
            "   Male: AUC = 0.671, Events = 212/22875\n",
            "\n",
            "Evaluating Bladder_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.705 (0.677-0.736) (calculated on 49870 individuals)\n",
            "Events (10-Year in Eval Cohort): 255 (0.5%) (from 50000 individuals)\n",
            "Excluded 130 prevalent cases for Bladder_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.681, Events = 148/27077\n",
            "   Male: AUC = 0.739, Events = 107/22793\n",
            "\n",
            "Evaluating Secondary_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.604 (0.591-0.618) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 1497 (3.0%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Secondary_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.583, Events = 857/27107\n",
            "   Male: AUC = 0.635, Events = 640/22893\n",
            "\n",
            "Evaluating Depression (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.471 (0.457-0.485) (calculated on 49510 individuals)\n",
            "Events (10-Year in Eval Cohort): 1995 (4.0%) (from 50000 individuals)\n",
            "Excluded 490 prevalent cases for Depression.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.467, Events = 1071/26809\n",
            "   Male: AUC = 0.487, Events = 909/22701\n",
            "\n",
            "Evaluating Anxiety (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.509 (0.492-0.525) (calculated on 49863 individuals)\n",
            "Events (10-Year in Eval Cohort): 1289 (2.6%) (from 50000 individuals)\n",
            "Excluded 137 prevalent cases for Anxiety.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.518, Events = 692/27021\n",
            "   Male: AUC = 0.502, Events = 597/22842\n",
            "\n",
            "Evaluating Bipolar_Disorder (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.454 (0.398-0.522) (calculated on 49925 individuals)\n",
            "Events (10-Year in Eval Cohort): 121 (0.2%) (from 50000 individuals)\n",
            "Excluded 75 prevalent cases for Bipolar_Disorder.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.481, Events = 69/27055\n",
            "   Male: AUC = 0.410, Events = 51/22870\n",
            "\n",
            "Evaluating Rheumatoid_Arthritis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.606 (0.587-0.627) (calculated on 49752 individuals)\n",
            "Events (10-Year in Eval Cohort): 595 (1.2%) (from 50000 individuals)\n",
            "Excluded 248 prevalent cases for Rheumatoid_Arthritis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.608, Events = 314/26913\n",
            "   Male: AUC = 0.605, Events = 279/22839\n",
            "\n",
            "Evaluating Psoriasis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.549 (0.514-0.597) (calculated on 49901 individuals)\n",
            "Events (10-Year in Eval Cohort): 236 (0.5%) (from 50000 individuals)\n",
            "Excluded 99 prevalent cases for Psoriasis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.537, Events = 111/27069\n",
            "   Male: AUC = 0.558, Events = 124/22832\n",
            "\n",
            "Evaluating Ulcerative_Colitis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.567 (0.535-0.600) (calculated on 49750 individuals)\n",
            "Events (10-Year in Eval Cohort): 248 (0.5%) (from 50000 individuals)\n",
            "Excluded 250 prevalent cases for Ulcerative_Colitis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.569, Events = 144/26979\n",
            "   Male: AUC = 0.569, Events = 103/22771\n",
            "\n",
            "Evaluating Crohns_Disease (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.555 (0.505-0.623) (calculated on 49850 individuals)\n",
            "Events (10-Year in Eval Cohort): 136 (0.3%) (from 50000 individuals)\n",
            "Excluded 150 prevalent cases for Crohns_Disease.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.571, Events = 77/27034\n",
            "   Male: AUC = 0.538, Events = 59/22816\n",
            "\n",
            "Evaluating Asthma (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.519 (0.512-0.531) (calculated on 48407 individuals)\n",
            "Events (10-Year in Eval Cohort): 3038 (6.1%) (from 50000 individuals)\n",
            "Excluded 1593 prevalent cases for Asthma.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.538, Events = 1591/26140\n",
            "   Male: AUC = 0.535, Events = 1350/22267\n",
            "\n",
            "Evaluating Parkinsons (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.731 (0.699-0.755) (calculated on 49971 individuals)\n",
            "Events (10-Year in Eval Cohort): 223 (0.4%) (from 50000 individuals)\n",
            "Excluded 29 prevalent cases for Parkinsons.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.744, Events = 124/27095\n",
            "   Male: AUC = 0.715, Events = 99/22876\n",
            "\n",
            "Evaluating Multiple_Sclerosis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.546 (0.482-0.601) (calculated on 49869 individuals)\n",
            "Events (10-Year in Eval Cohort): 97 (0.2%) (from 50000 individuals)\n",
            "Excluded 131 prevalent cases for Multiple_Sclerosis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.528, Events = 61/27009\n",
            "   Male: AUC = 0.579, Events = 36/22860\n",
            "\n",
            "Evaluating Thyroid_Disorders (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.563 (0.550-0.575) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2238 (4.5%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.572, Events = 1792/27107\n",
            "   Male: AUC = 0.557, Events = 446/22893\n",
            "\n",
            "Summary of Results (Prospective 10-Year Outcome, 1-Year Score, Sex-Adjusted):\n",
            "--------------------------------------------------------------------------------\n",
            "Disease Group        AUC                       Events     Rate (%)  \n",
            "--------------------------------------------------------------------------------\n",
            "ASCVD                0.695 (0.686-0.702)       4333       8.7\n",
            "Diabetes             0.603 (0.591-0.612)       2921       5.8\n",
            "Atrial_Fib           0.704 (0.694-0.714)       1919       3.8\n",
            "CKD                  0.704 (0.689-0.718)       1135       2.3\n",
            "All_Cancers          0.669 (0.660-0.681)       2521       5.0\n",
            "Stroke               0.675 (0.653-0.695)       692        1.4\n",
            "Heart_Failure        0.704 (0.688-0.717)       991        2.0\n",
            "Pneumonia            0.649 (0.638-0.662)       1758       3.5\n",
            "COPD                 0.663 (0.653-0.674)       2071       4.1\n",
            "Osteoporosis         0.669 (0.655-0.680)       1101       2.2\n",
            "Anemia               0.595 (0.583-0.606)       2676       5.4\n",
            "Colorectal_Cancer    0.647 (0.624-0.669)       613        1.2\n",
            "Breast_Cancer        0.541 (0.522-0.556)       1098       4.1\n",
            "Prostate_Cancer      0.678 (0.664-0.690)       952        4.2\n",
            "Lung_Cancer          0.673 (0.651-0.697)       432        0.9\n",
            "Bladder_Cancer       0.705 (0.677-0.736)       255        0.5\n",
            "Secondary_Cancer     0.604 (0.591-0.618)       1497       3.0\n",
            "Depression           0.471 (0.457-0.485)       1995       4.0\n",
            "Anxiety              0.509 (0.492-0.525)       1289       2.6\n",
            "Bipolar_Disorder     0.454 (0.398-0.522)       121        0.2\n",
            "Rheumatoid_Arthritis 0.606 (0.587-0.627)       595        1.2\n",
            "Psoriasis            0.549 (0.514-0.597)       236        0.5\n",
            "Ulcerative_Colitis   0.567 (0.535-0.600)       248        0.5\n",
            "Crohns_Disease       0.555 (0.505-0.623)       136        0.3\n",
            "Asthma               0.519 (0.512-0.531)       3038       6.1\n",
            "Parkinsons           0.731 (0.699-0.755)       223        0.4\n",
            "Multiple_Sclerosis   0.546 (0.482-0.601)       97         0.2\n",
            "Thyroid_Disorders    0.563 (0.550-0.575)       2238       4.5\n",
            "--------------------------------------------------------------------------------\n",
            "Evaluating dynamic 1-year AUC...\n",
            "Filtering for 1: Found 22893 individuals in cohort\n",
            "\n",
            "Summary of Results (1-Year Risk, Sex-Adjusted, Offset=0):\n",
            "--------------------------------------------------------------------------------\n",
            "Disease Group        AUC                       Events     Rate (%)   C-index   \n",
            "--------------------------------------------------------------------------------\n",
            "ASCVD                0.870 (0.853-0.900)       397        0.8        N/A\n",
            "Diabetes             0.685 (0.645-0.729)       195        0.4        N/A\n",
            "Atrial_Fib           0.828 (0.782-0.867)       120        0.2        N/A\n",
            "CKD                  0.680 (0.525-0.816)       16         0.0        N/A\n",
            "All_Cancers          0.731 (0.692-0.774)       115        0.2        N/A\n",
            "Stroke               0.659 (0.585-0.722)       30         0.1        N/A\n",
            "Heart_Failure        0.804 (0.727-0.874)       51         0.1        N/A\n",
            "Pneumonia            0.609 (0.536-0.670)       56         0.1        N/A\n",
            "COPD                 0.727 (0.679-0.777)       99         0.2        N/A\n",
            "Osteoporosis         0.782 (0.676-0.838)       44         0.1        N/A\n",
            "Anemia               0.635 (0.588-0.686)       144        0.3        N/A\n",
            "Colorectal_Cancer    0.847 (0.793-0.909)       37         0.1        N/A\n",
            "Breast_Cancer        0.841 (0.779-0.896)       89         0.2        N/A\n",
            "Prostate_Cancer      0.799 (0.728-0.848)       56         0.2        N/A\n",
            "Lung_Cancer          0.748 (0.605-0.874)       11         0.0        N/A\n",
            "Bladder_Cancer       0.827 (0.643-0.967)       9          0.0        N/A\n",
            "Secondary_Cancer     0.598 (0.506-0.658)       51         0.1        N/A\n",
            "Depression           0.665 (0.603-0.755)       62         0.1        N/A\n",
            "Anxiety              0.680 (0.552-0.826)       24         0.0        N/A\n",
            "Bipolar_Disorder     0.869 (0.693-0.990)       4          0.0        N/A\n",
            "Rheumatoid_Arthritis 0.801 (0.681-0.880)       34         0.1        N/A\n",
            "Psoriasis            0.722 (0.587-0.894)       9          0.0        N/A\n",
            "Ulcerative_Colitis   0.943 (0.890-0.983)       17         0.0        N/A\n",
            "Crohns_Disease       0.966 (0.944-0.984)       7          0.0        N/A\n",
            "Asthma               0.663 (0.625-0.694)       251        0.5        N/A\n",
            "Parkinsons           0.783 (0.623-0.927)       10         0.0        N/A\n",
            "Multiple_Sclerosis   0.951 (0.927-0.966)       13         0.0        N/A\n",
            "Thyroid_Disorders    0.653 (0.611-0.702)       137        0.3        N/A\n",
            "--------------------------------------------------------------------------------\n",
            "  ✓ Static 10-year: 28 diseases\n",
            "  ✓ Dynamic 1-year: 28 diseases\n",
            "\n",
            "================================================================================\n",
            "SUMMARY\n",
            "================================================================================\n",
            "Evaluated 4 configurations\n",
            "Static 10-year AUC: 112 disease-config combinations\n",
            "Dynamic 1-year AUC: 112 disease-config combinations\n",
            "\n",
            "Results saved to:\n",
            "  - /Users/sarahurbut/aladynoulli2/pyScripts/dec_6_revision/new_notebooks/results/all_4_configs_5batches_static_10yr_auc_results.csv\n",
            "  - /Users/sarahurbut/aladynoulli2/pyScripts/dec_6_revision/new_notebooks/results/all_4_configs_5batches_dynamic_1yr_auc_results.csv\n",
            "================================================================================\n",
            "COMPLETED\n",
            "================================================================================\n"
          ]
        }
      ],
      "source": [
        "%run evaluate_all_4_configs_5batches_auc.py --n_bootstraps 100"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 3,
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "================================================================================\n",
            "EVALUATING ALL 5 CONFIGURATIONS - FIRST 5 BATCHES (50K PATIENTS)\n",
            "================================================================================\n",
            "Batch size: 10000\n",
            "Number of batches: 5\n",
            "Total patients: 50,000\n",
            "Bootstrap iterations: 10\n",
            "================================================================================\n",
            "\n",
            "Loading data files...\n",
            "✓ Loaded Y: torch.Size([50000, 348, 52]), E: torch.Size([50000, 348]), pce_df: 50000 rows\n",
            "\n",
            "================================================================================\n",
            "CONFIGURATION: FIXEDK_FREEG\n",
            "Directory: /Users/sarahurbut/Library/CloudStorage/Dropbox/enrollment_predictions_fixedphi_fixedk_freeg_vectorized/\n",
            "================================================================================\n",
            "  Pooling 5 batches from enrollment_predictions_fixedphi_fixedk_freeg_vectorized...\n",
            "    ✓ Batch 0: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 1: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 2: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 3: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 4: torch.Size([10000, 348, 52])\n",
            "  ✓ Pooled shape: torch.Size([50000, 348, 52])\n",
            "\n",
            "================================================================================\n",
            "EVALUATING: FIXEDK_FREEG\n",
            "================================================================================\n",
            "\n",
            "Evaluating static 10-year AUC...\n",
            "\n",
            "Evaluating ASCVD (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.732 (0.728-0.736) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 4333 (8.7%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for ASCVD.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.710, Events = 1446/27107\n",
            "   Male: AUC = 0.714, Events = 2887/22893\n",
            "\n",
            "   ASCVD risk in patients with pre-existing conditions:\n",
            "   RA: AUC = 0.710, Events = 36/248\n",
            "   Breast_Cancer: AUC = 0.658, Events = 48/840\n",
            "\n",
            "Evaluating Diabetes (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.629 (0.620-0.635) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2921 (5.8%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Diabetes.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.623, Events = 1193/27107\n",
            "   Male: AUC = 0.625, Events = 1728/22893\n",
            "\n",
            "Evaluating Atrial_Fib (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.709 (0.702-0.715) (calculated on 49353 individuals)\n",
            "Events (10-Year in Eval Cohort): 1919 (3.8%) (from 50000 individuals)\n",
            "Excluded 647 prevalent cases for Atrial_Fib.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.713, Events = 1041/26933\n",
            "   Male: AUC = 0.712, Events = 852/22420\n",
            "\n",
            "Evaluating CKD (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.703 (0.685-0.712) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 1135 (2.3%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for CKD.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.708, Events = 530/27107\n",
            "   Male: AUC = 0.696, Events = 605/22893\n",
            "\n",
            "Evaluating All_Cancers (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.674 (0.668-0.678) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2521 (5.0%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for All_Cancers.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.640, Events = 785/27107\n",
            "   Male: AUC = 0.676, Events = 1736/22893\n",
            "\n",
            "Evaluating Stroke (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.676 (0.655-0.692) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 692 (1.4%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Stroke.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.673, Events = 313/27107\n",
            "   Male: AUC = 0.674, Events = 379/22893\n",
            "\n",
            "Evaluating Heart_Failure (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.705 (0.701-0.719) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 991 (2.0%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Heart_Failure.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.732, Events = 352/27107\n",
            "   Male: AUC = 0.680, Events = 639/22893\n",
            "\n",
            "Evaluating Pneumonia (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.650 (0.635-0.657) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 1758 (3.5%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Pneumonia.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.650, Events = 773/27107\n",
            "   Male: AUC = 0.644, Events = 985/22893\n",
            "\n",
            "Evaluating COPD (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.665 (0.655-0.671) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2071 (4.1%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for COPD.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.667, Events = 925/27107\n",
            "   Male: AUC = 0.658, Events = 1146/22893\n",
            "\n",
            "Evaluating Osteoporosis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.675 (0.666-0.686) (calculated on 49858 individuals)\n",
            "Events (10-Year in Eval Cohort): 1101 (2.2%) (from 50000 individuals)\n",
            "Excluded 142 prevalent cases for Osteoporosis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.675, Events = 611/26995\n",
            "   Male: AUC = 0.677, Events = 489/22863\n",
            "\n",
            "Evaluating Anemia (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.595 (0.587-0.600) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2676 (5.4%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Anemia.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.568, Events = 1430/27107\n",
            "   Male: AUC = 0.625, Events = 1246/22893\n",
            "\n",
            "Evaluating Colorectal_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.653 (0.652-0.673) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 613 (1.2%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.630, Events = 282/27107\n",
            "   Male: AUC = 0.669, Events = 331/22893\n",
            "\n",
            "Evaluating Breast_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "Filtering for Female: Found 27107 individuals in cohort\n",
            "AUC: 0.548 (0.539-0.565) (calculated on 27107 individuals)\n",
            "Events (10-Year in Eval Cohort): 1098 (4.1%) (from 27107 individuals)\n",
            "Excluded 0 prevalent cases for Breast_Cancer.\n",
            "\n",
            "Evaluating Prostate_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "Filtering for Male: Found 22893 individuals in cohort\n",
            "AUC: 0.681 (0.670-0.687) (calculated on 22640 individuals)\n",
            "Events (10-Year in Eval Cohort): 952 (4.2%) (from 22893 individuals)\n",
            "Excluded 253 prevalent cases for Prostate_Cancer.\n",
            "\n",
            "Evaluating Lung_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.675 (0.658-0.704) (calculated on 49963 individuals)\n",
            "Events (10-Year in Eval Cohort): 432 (0.9%) (from 50000 individuals)\n",
            "Excluded 37 prevalent cases for Lung_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.681, Events = 218/27088\n",
            "   Male: AUC = 0.671, Events = 212/22875\n",
            "\n",
            "Evaluating Bladder_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.716 (0.686-0.738) (calculated on 49870 individuals)\n",
            "Events (10-Year in Eval Cohort): 255 (0.5%) (from 50000 individuals)\n",
            "Excluded 130 prevalent cases for Bladder_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.693, Events = 148/27077\n",
            "   Male: AUC = 0.749, Events = 107/22793\n",
            "\n",
            "Evaluating Secondary_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.607 (0.590-0.616) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 1497 (3.0%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Secondary_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.586, Events = 857/27107\n",
            "   Male: AUC = 0.636, Events = 640/22893\n",
            "\n",
            "Evaluating Depression (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.478 (0.462-0.486) (calculated on 49510 individuals)\n",
            "Events (10-Year in Eval Cohort): 1995 (4.0%) (from 50000 individuals)\n",
            "Excluded 490 prevalent cases for Depression.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.475, Events = 1071/26809\n",
            "   Male: AUC = 0.493, Events = 909/22701\n",
            "\n",
            "Evaluating Anxiety (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.515 (0.501-0.525) (calculated on 49863 individuals)\n",
            "Events (10-Year in Eval Cohort): 1289 (2.6%) (from 50000 individuals)\n",
            "Excluded 137 prevalent cases for Anxiety.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.523, Events = 692/27021\n",
            "   Male: AUC = 0.510, Events = 597/22842\n",
            "\n",
            "Evaluating Bipolar_Disorder (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.451 (0.415-0.494) (calculated on 49925 individuals)\n",
            "Events (10-Year in Eval Cohort): 121 (0.2%) (from 50000 individuals)\n",
            "Excluded 75 prevalent cases for Bipolar_Disorder.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.467, Events = 69/27055\n",
            "   Male: AUC = 0.421, Events = 51/22870\n",
            "\n",
            "Evaluating Rheumatoid_Arthritis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.611 (0.606-0.628) (calculated on 49752 individuals)\n",
            "Events (10-Year in Eval Cohort): 595 (1.2%) (from 50000 individuals)\n",
            "Excluded 248 prevalent cases for Rheumatoid_Arthritis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.617, Events = 314/26913\n",
            "   Male: AUC = 0.608, Events = 279/22839\n",
            "\n",
            "Evaluating Psoriasis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.550 (0.521-0.579) (calculated on 49901 individuals)\n",
            "Events (10-Year in Eval Cohort): 236 (0.5%) (from 50000 individuals)\n",
            "Excluded 99 prevalent cases for Psoriasis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.532, Events = 111/27069\n",
            "   Male: AUC = 0.565, Events = 124/22832\n",
            "\n",
            "Evaluating Ulcerative_Colitis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.572 (0.560-0.599) (calculated on 49750 individuals)\n",
            "Events (10-Year in Eval Cohort): 248 (0.5%) (from 50000 individuals)\n",
            "Excluded 250 prevalent cases for Ulcerative_Colitis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.575, Events = 144/26979\n",
            "   Male: AUC = 0.571, Events = 103/22771\n",
            "\n",
            "Evaluating Crohns_Disease (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.577 (0.526-0.610) (calculated on 49850 individuals)\n",
            "Events (10-Year in Eval Cohort): 136 (0.3%) (from 50000 individuals)\n",
            "Excluded 150 prevalent cases for Crohns_Disease.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.591, Events = 77/27034\n",
            "   Male: AUC = 0.561, Events = 59/22816\n",
            "\n",
            "Evaluating Asthma (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.526 (0.522-0.532) (calculated on 48407 individuals)\n",
            "Events (10-Year in Eval Cohort): 3038 (6.1%) (from 50000 individuals)\n",
            "Excluded 1593 prevalent cases for Asthma.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.544, Events = 1591/26140\n",
            "   Male: AUC = 0.543, Events = 1350/22267\n",
            "\n",
            "Evaluating Parkinsons (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.728 (0.719-0.751) (calculated on 49971 individuals)\n",
            "Events (10-Year in Eval Cohort): 223 (0.4%) (from 50000 individuals)\n",
            "Excluded 29 prevalent cases for Parkinsons.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.740, Events = 124/27095\n",
            "   Male: AUC = 0.714, Events = 99/22876\n",
            "\n",
            "Evaluating Multiple_Sclerosis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.529 (0.482-0.567) (calculated on 49869 individuals)\n",
            "Events (10-Year in Eval Cohort): 97 (0.2%) (from 50000 individuals)\n",
            "Excluded 131 prevalent cases for Multiple_Sclerosis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.521, Events = 61/27009\n",
            "   Male: AUC = 0.544, Events = 36/22860\n",
            "\n",
            "Evaluating Thyroid_Disorders (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.574 (0.571-0.584) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2238 (4.5%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.574, Events = 1792/27107\n",
            "   Male: AUC = 0.561, Events = 446/22893\n",
            "\n",
            "Summary of Results (Prospective 10-Year Outcome, 1-Year Score, Sex-Adjusted):\n",
            "--------------------------------------------------------------------------------\n",
            "Disease Group        AUC                       Events     Rate (%)  \n",
            "--------------------------------------------------------------------------------\n",
            "ASCVD                0.732 (0.728-0.736)       4333       8.7\n",
            "Diabetes             0.629 (0.620-0.635)       2921       5.8\n",
            "Atrial_Fib           0.709 (0.702-0.715)       1919       3.8\n",
            "CKD                  0.703 (0.685-0.712)       1135       2.3\n",
            "All_Cancers          0.674 (0.668-0.678)       2521       5.0\n",
            "Stroke               0.676 (0.655-0.692)       692        1.4\n",
            "Heart_Failure        0.705 (0.701-0.719)       991        2.0\n",
            "Pneumonia            0.650 (0.635-0.657)       1758       3.5\n",
            "COPD                 0.665 (0.655-0.671)       2071       4.1\n",
            "Osteoporosis         0.675 (0.666-0.686)       1101       2.2\n",
            "Anemia               0.595 (0.587-0.600)       2676       5.4\n",
            "Colorectal_Cancer    0.653 (0.652-0.673)       613        1.2\n",
            "Breast_Cancer        0.548 (0.539-0.565)       1098       4.1\n",
            "Prostate_Cancer      0.681 (0.670-0.687)       952        4.2\n",
            "Lung_Cancer          0.675 (0.658-0.704)       432        0.9\n",
            "Bladder_Cancer       0.716 (0.686-0.738)       255        0.5\n",
            "Secondary_Cancer     0.607 (0.590-0.616)       1497       3.0\n",
            "Depression           0.478 (0.462-0.486)       1995       4.0\n",
            "Anxiety              0.515 (0.501-0.525)       1289       2.6\n",
            "Bipolar_Disorder     0.451 (0.415-0.494)       121        0.2\n",
            "Rheumatoid_Arthritis 0.611 (0.606-0.628)       595        1.2\n",
            "Psoriasis            0.550 (0.521-0.579)       236        0.5\n",
            "Ulcerative_Colitis   0.572 (0.560-0.599)       248        0.5\n",
            "Crohns_Disease       0.577 (0.526-0.610)       136        0.3\n",
            "Asthma               0.526 (0.522-0.532)       3038       6.1\n",
            "Parkinsons           0.728 (0.719-0.751)       223        0.4\n",
            "Multiple_Sclerosis   0.529 (0.482-0.567)       97         0.2\n",
            "Thyroid_Disorders    0.574 (0.571-0.584)       2238       4.5\n",
            "--------------------------------------------------------------------------------\n",
            "Evaluating dynamic 1-year AUC...\n",
            "Filtering for 1: Found 22893 individuals in cohort\n",
            "\n",
            "Summary of Results (1-Year Risk, Sex-Adjusted, Offset=0):\n",
            "--------------------------------------------------------------------------------\n",
            "Disease Group        AUC                       Events     Rate (%)   C-index   \n",
            "--------------------------------------------------------------------------------\n",
            "ASCVD                0.873 (0.859-0.883)       397        0.8        N/A\n",
            "Diabetes             0.715 (0.675-0.755)       195        0.4        N/A\n",
            "Atrial_Fib           0.837 (0.792-0.867)       120        0.2        N/A\n",
            "CKD                  0.683 (0.545-0.795)       16         0.0        N/A\n",
            "All_Cancers          0.737 (0.714-0.782)       115        0.2        N/A\n",
            "Stroke               0.659 (0.594-0.688)       30         0.1        N/A\n",
            "Heart_Failure        0.812 (0.775-0.851)       51         0.1        N/A\n",
            "Pneumonia            0.611 (0.593-0.666)       56         0.1        N/A\n",
            "COPD                 0.725 (0.661-0.739)       99         0.2        N/A\n",
            "Osteoporosis         0.786 (0.734-0.834)       44         0.1        N/A\n",
            "Anemia               0.632 (0.595-0.630)       144        0.3        N/A\n",
            "Colorectal_Cancer    0.851 (0.808-0.913)       37         0.1        N/A\n",
            "Breast_Cancer        0.834 (0.779-0.895)       89         0.2        N/A\n",
            "Prostate_Cancer      0.801 (0.759-0.818)       56         0.2        N/A\n",
            "Lung_Cancer          0.745 (0.518-0.900)       11         0.0        N/A\n",
            "Bladder_Cancer       0.824 (0.585-0.913)       9          0.0        N/A\n",
            "Secondary_Cancer     0.599 (0.565-0.672)       51         0.1        N/A\n",
            "Depression           0.669 (0.570-0.713)       62         0.1        N/A\n",
            "Anxiety              0.684 (0.572-0.767)       24         0.0        N/A\n",
            "Bipolar_Disorder     0.734 (0.496-0.954)       4          0.0        N/A\n",
            "Rheumatoid_Arthritis 0.804 (0.718-0.828)       34         0.1        N/A\n",
            "Psoriasis            0.685 (0.604-0.828)       9          0.0        N/A\n",
            "Ulcerative_Colitis   0.935 (0.913-0.983)       17         0.0        N/A\n",
            "Crohns_Disease       0.970 (0.951-0.977)       7          0.0        N/A\n",
            "Asthma               0.666 (0.663-0.700)       251        0.5        N/A\n",
            "Parkinsons           0.769 (0.731-0.903)       10         0.0        N/A\n",
            "Multiple_Sclerosis   0.938 (0.894-0.968)       13         0.0        N/A\n",
            "Thyroid_Disorders    0.658 (0.612-0.712)       137        0.3        N/A\n",
            "--------------------------------------------------------------------------------\n",
            "  ✓ Static 10-year: 28 diseases\n",
            "  ✓ Dynamic 1-year: 28 diseases\n",
            "\n",
            "================================================================================\n",
            "CONFIGURATION: FIXEDG_FREEK\n",
            "Directory: /Users/sarahurbut/Library/CloudStorage/Dropbox/enrollment_predictions_fixedphi_fixedg_freek_vectorized/\n",
            "================================================================================\n",
            "  Pooling 5 batches from enrollment_predictions_fixedphi_fixedg_freek_vectorized...\n",
            "    ✓ Batch 0: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 1: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 2: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 3: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 4: torch.Size([10000, 348, 52])\n",
            "  ✓ Pooled shape: torch.Size([50000, 348, 52])\n",
            "\n",
            "================================================================================\n",
            "EVALUATING: FIXEDG_FREEK\n",
            "================================================================================\n",
            "\n",
            "Evaluating static 10-year AUC...\n",
            "\n",
            "Evaluating ASCVD (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.695 (0.691-0.705) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 4333 (8.7%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for ASCVD.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.692, Events = 1446/27107\n",
            "   Male: AUC = 0.688, Events = 2887/22893\n",
            "\n",
            "   ASCVD risk in patients with pre-existing conditions:\n",
            "   RA: AUC = 0.675, Events = 36/248\n",
            "   Breast_Cancer: AUC = 0.644, Events = 48/840\n",
            "\n",
            "Evaluating Diabetes (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.603 (0.594-0.611) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2921 (5.8%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Diabetes.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.598, Events = 1193/27107\n",
            "   Male: AUC = 0.601, Events = 1728/22893\n",
            "\n",
            "Evaluating Atrial_Fib (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.704 (0.701-0.711) (calculated on 49353 individuals)\n",
            "Events (10-Year in Eval Cohort): 1919 (3.8%) (from 50000 individuals)\n",
            "Excluded 647 prevalent cases for Atrial_Fib.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.708, Events = 1041/26933\n",
            "   Male: AUC = 0.708, Events = 852/22420\n",
            "\n",
            "Evaluating CKD (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.705 (0.694-0.714) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 1135 (2.3%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for CKD.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.709, Events = 530/27107\n",
            "   Male: AUC = 0.697, Events = 605/22893\n",
            "\n",
            "Evaluating All_Cancers (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.669 (0.661-0.676) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2521 (5.0%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for All_Cancers.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.639, Events = 785/27107\n",
            "   Male: AUC = 0.674, Events = 1736/22893\n",
            "\n",
            "Evaluating Stroke (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.675 (0.665-0.691) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 692 (1.4%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Stroke.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.672, Events = 313/27107\n",
            "   Male: AUC = 0.673, Events = 379/22893\n",
            "\n",
            "Evaluating Heart_Failure (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.704 (0.688-0.718) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 991 (2.0%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Heart_Failure.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.732, Events = 352/27107\n",
            "   Male: AUC = 0.680, Events = 639/22893\n",
            "\n",
            "Evaluating Pneumonia (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.649 (0.637-0.660) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 1758 (3.5%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Pneumonia.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.649, Events = 773/27107\n",
            "   Male: AUC = 0.645, Events = 985/22893\n",
            "\n",
            "Evaluating COPD (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.664 (0.662-0.670) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2071 (4.1%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for COPD.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.666, Events = 925/27107\n",
            "   Male: AUC = 0.657, Events = 1146/22893\n",
            "\n",
            "Evaluating Osteoporosis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.669 (0.657-0.687) (calculated on 49858 individuals)\n",
            "Events (10-Year in Eval Cohort): 1101 (2.2%) (from 50000 individuals)\n",
            "Excluded 142 prevalent cases for Osteoporosis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.669, Events = 611/26995\n",
            "   Male: AUC = 0.670, Events = 489/22863\n",
            "\n",
            "Evaluating Anemia (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.595 (0.590-0.597) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2676 (5.4%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Anemia.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.567, Events = 1430/27107\n",
            "   Male: AUC = 0.626, Events = 1246/22893\n",
            "\n",
            "Evaluating Colorectal_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.647 (0.624-0.672) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 613 (1.2%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.624, Events = 282/27107\n",
            "   Male: AUC = 0.663, Events = 331/22893\n",
            "\n",
            "Evaluating Breast_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "Filtering for Female: Found 27107 individuals in cohort\n",
            "AUC: 0.542 (0.530-0.570) (calculated on 27107 individuals)\n",
            "Events (10-Year in Eval Cohort): 1098 (4.1%) (from 27107 individuals)\n",
            "Excluded 0 prevalent cases for Breast_Cancer.\n",
            "\n",
            "Evaluating Prostate_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "Filtering for Male: Found 22893 individuals in cohort\n",
            "AUC: 0.678 (0.669-0.680) (calculated on 22640 individuals)\n",
            "Events (10-Year in Eval Cohort): 952 (4.2%) (from 22893 individuals)\n",
            "Excluded 253 prevalent cases for Prostate_Cancer.\n",
            "\n",
            "Evaluating Lung_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.673 (0.657-0.689) (calculated on 49963 individuals)\n",
            "Events (10-Year in Eval Cohort): 432 (0.9%) (from 50000 individuals)\n",
            "Excluded 37 prevalent cases for Lung_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.679, Events = 218/27088\n",
            "   Male: AUC = 0.671, Events = 212/22875\n",
            "\n",
            "Evaluating Bladder_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.704 (0.679-0.725) (calculated on 49870 individuals)\n",
            "Events (10-Year in Eval Cohort): 255 (0.5%) (from 50000 individuals)\n",
            "Excluded 130 prevalent cases for Bladder_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.680, Events = 148/27077\n",
            "   Male: AUC = 0.738, Events = 107/22793\n",
            "\n",
            "Evaluating Secondary_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.605 (0.595-0.619) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 1497 (3.0%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Secondary_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.583, Events = 857/27107\n",
            "   Male: AUC = 0.635, Events = 640/22893\n",
            "\n",
            "Evaluating Depression (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.471 (0.462-0.479) (calculated on 49510 individuals)\n",
            "Events (10-Year in Eval Cohort): 1995 (4.0%) (from 50000 individuals)\n",
            "Excluded 490 prevalent cases for Depression.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.467, Events = 1071/26809\n",
            "   Male: AUC = 0.486, Events = 909/22701\n",
            "\n",
            "Evaluating Anxiety (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.509 (0.488-0.521) (calculated on 49863 individuals)\n",
            "Events (10-Year in Eval Cohort): 1289 (2.6%) (from 50000 individuals)\n",
            "Excluded 137 prevalent cases for Anxiety.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.518, Events = 692/27021\n",
            "   Male: AUC = 0.502, Events = 597/22842\n",
            "\n",
            "Evaluating Bipolar_Disorder (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.452 (0.422-0.513) (calculated on 49925 individuals)\n",
            "Events (10-Year in Eval Cohort): 121 (0.2%) (from 50000 individuals)\n",
            "Excluded 75 prevalent cases for Bipolar_Disorder.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.477, Events = 69/27055\n",
            "   Male: AUC = 0.409, Events = 51/22870\n",
            "\n",
            "Evaluating Rheumatoid_Arthritis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.606 (0.574-0.627) (calculated on 49752 individuals)\n",
            "Events (10-Year in Eval Cohort): 595 (1.2%) (from 50000 individuals)\n",
            "Excluded 248 prevalent cases for Rheumatoid_Arthritis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.608, Events = 314/26913\n",
            "   Male: AUC = 0.606, Events = 279/22839\n",
            "\n",
            "Evaluating Psoriasis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.549 (0.527-0.591) (calculated on 49901 individuals)\n",
            "Events (10-Year in Eval Cohort): 236 (0.5%) (from 50000 individuals)\n",
            "Excluded 99 prevalent cases for Psoriasis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.537, Events = 111/27069\n",
            "   Male: AUC = 0.558, Events = 124/22832\n",
            "\n",
            "Evaluating Ulcerative_Colitis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.568 (0.541-0.597) (calculated on 49750 individuals)\n",
            "Events (10-Year in Eval Cohort): 248 (0.5%) (from 50000 individuals)\n",
            "Excluded 250 prevalent cases for Ulcerative_Colitis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.570, Events = 144/26979\n",
            "   Male: AUC = 0.569, Events = 103/22771\n",
            "\n",
            "Evaluating Crohns_Disease (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.557 (0.513-0.577) (calculated on 49850 individuals)\n",
            "Events (10-Year in Eval Cohort): 136 (0.3%) (from 50000 individuals)\n",
            "Excluded 150 prevalent cases for Crohns_Disease.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.574, Events = 77/27034\n",
            "   Male: AUC = 0.538, Events = 59/22816\n",
            "\n",
            "Evaluating Asthma (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.519 (0.509-0.526) (calculated on 48407 individuals)\n",
            "Events (10-Year in Eval Cohort): 3038 (6.1%) (from 50000 individuals)\n",
            "Excluded 1593 prevalent cases for Asthma.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.538, Events = 1591/26140\n",
            "   Male: AUC = 0.535, Events = 1350/22267\n",
            "\n",
            "Evaluating Parkinsons (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.731 (0.718-0.748) (calculated on 49971 individuals)\n",
            "Events (10-Year in Eval Cohort): 223 (0.4%) (from 50000 individuals)\n",
            "Excluded 29 prevalent cases for Parkinsons.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.744, Events = 124/27095\n",
            "   Male: AUC = 0.715, Events = 99/22876\n",
            "\n",
            "Evaluating Multiple_Sclerosis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.542 (0.497-0.593) (calculated on 49869 individuals)\n",
            "Events (10-Year in Eval Cohort): 97 (0.2%) (from 50000 individuals)\n",
            "Excluded 131 prevalent cases for Multiple_Sclerosis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.523, Events = 61/27009\n",
            "   Male: AUC = 0.577, Events = 36/22860\n",
            "\n",
            "Evaluating Thyroid_Disorders (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.563 (0.554-0.579) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2238 (4.5%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.572, Events = 1792/27107\n",
            "   Male: AUC = 0.557, Events = 446/22893\n",
            "\n",
            "Summary of Results (Prospective 10-Year Outcome, 1-Year Score, Sex-Adjusted):\n",
            "--------------------------------------------------------------------------------\n",
            "Disease Group        AUC                       Events     Rate (%)  \n",
            "--------------------------------------------------------------------------------\n",
            "ASCVD                0.695 (0.691-0.705)       4333       8.7\n",
            "Diabetes             0.603 (0.594-0.611)       2921       5.8\n",
            "Atrial_Fib           0.704 (0.701-0.711)       1919       3.8\n",
            "CKD                  0.705 (0.694-0.714)       1135       2.3\n",
            "All_Cancers          0.669 (0.661-0.676)       2521       5.0\n",
            "Stroke               0.675 (0.665-0.691)       692        1.4\n",
            "Heart_Failure        0.704 (0.688-0.718)       991        2.0\n",
            "Pneumonia            0.649 (0.637-0.660)       1758       3.5\n",
            "COPD                 0.664 (0.662-0.670)       2071       4.1\n",
            "Osteoporosis         0.669 (0.657-0.687)       1101       2.2\n",
            "Anemia               0.595 (0.590-0.597)       2676       5.4\n",
            "Colorectal_Cancer    0.647 (0.624-0.672)       613        1.2\n",
            "Breast_Cancer        0.542 (0.530-0.570)       1098       4.1\n",
            "Prostate_Cancer      0.678 (0.669-0.680)       952        4.2\n",
            "Lung_Cancer          0.673 (0.657-0.689)       432        0.9\n",
            "Bladder_Cancer       0.704 (0.679-0.725)       255        0.5\n",
            "Secondary_Cancer     0.605 (0.595-0.619)       1497       3.0\n",
            "Depression           0.471 (0.462-0.479)       1995       4.0\n",
            "Anxiety              0.509 (0.488-0.521)       1289       2.6\n",
            "Bipolar_Disorder     0.452 (0.422-0.513)       121        0.2\n",
            "Rheumatoid_Arthritis 0.606 (0.574-0.627)       595        1.2\n",
            "Psoriasis            0.549 (0.527-0.591)       236        0.5\n",
            "Ulcerative_Colitis   0.568 (0.541-0.597)       248        0.5\n",
            "Crohns_Disease       0.557 (0.513-0.577)       136        0.3\n",
            "Asthma               0.519 (0.509-0.526)       3038       6.1\n",
            "Parkinsons           0.731 (0.718-0.748)       223        0.4\n",
            "Multiple_Sclerosis   0.542 (0.497-0.593)       97         0.2\n",
            "Thyroid_Disorders    0.563 (0.554-0.579)       2238       4.5\n",
            "--------------------------------------------------------------------------------\n",
            "Evaluating dynamic 1-year AUC...\n",
            "Filtering for 1: Found 22893 individuals in cohort\n",
            "\n",
            "Summary of Results (1-Year Risk, Sex-Adjusted, Offset=0):\n",
            "--------------------------------------------------------------------------------\n",
            "Disease Group        AUC                       Events     Rate (%)   C-index   \n",
            "--------------------------------------------------------------------------------\n",
            "ASCVD                0.870 (0.845-0.882)       397        0.8        N/A\n",
            "Diabetes             0.685 (0.665-0.724)       195        0.4        N/A\n",
            "Atrial_Fib           0.828 (0.793-0.872)       120        0.2        N/A\n",
            "CKD                  0.680 (0.472-0.808)       16         0.0        N/A\n",
            "All_Cancers          0.731 (0.705-0.751)       115        0.2        N/A\n",
            "Stroke               0.657 (0.605-0.702)       30         0.1        N/A\n",
            "Heart_Failure        0.803 (0.757-0.836)       51         0.1        N/A\n",
            "Pneumonia            0.609 (0.528-0.654)       56         0.1        N/A\n",
            "COPD                 0.726 (0.680-0.758)       99         0.2        N/A\n",
            "Osteoporosis         0.782 (0.754-0.827)       44         0.1        N/A\n",
            "Anemia               0.636 (0.596-0.683)       144        0.3        N/A\n",
            "Colorectal_Cancer    0.851 (0.837-0.896)       37         0.1        N/A\n",
            "Breast_Cancer        0.840 (0.796-0.861)       89         0.2        N/A\n",
            "Prostate_Cancer      0.799 (0.768-0.823)       56         0.2        N/A\n",
            "Lung_Cancer          0.747 (0.681-0.917)       11         0.0        N/A\n",
            "Bladder_Cancer       0.825 (0.664-0.942)       9          0.0        N/A\n",
            "Secondary_Cancer     0.598 (0.517-0.685)       51         0.1        N/A\n",
            "Depression           0.664 (0.614-0.739)       62         0.1        N/A\n",
            "Anxiety              0.679 (0.561-0.796)       24         0.0        N/A\n",
            "Bipolar_Disorder     0.847 (0.767-0.978)       4          0.0        N/A\n",
            "Rheumatoid_Arthritis 0.799 (0.739-0.863)       34         0.1        N/A\n",
            "Psoriasis            0.720 (0.653-0.845)       9          0.0        N/A\n",
            "Ulcerative_Colitis   0.946 (0.897-0.990)       17         0.0        N/A\n",
            "Crohns_Disease       0.965 (0.955-0.978)       7          0.0        N/A\n",
            "Asthma               0.663 (0.640-0.688)       251        0.5        N/A\n",
            "Parkinsons           0.782 (0.714-0.849)       10         0.0        N/A\n",
            "Multiple_Sclerosis   0.947 (0.926-0.969)       13         0.0        N/A\n",
            "Thyroid_Disorders    0.652 (0.589-0.664)       137        0.3        N/A\n",
            "--------------------------------------------------------------------------------\n",
            "  ✓ Static 10-year: 28 diseases\n",
            "  ✓ Dynamic 1-year: 28 diseases\n",
            "\n",
            "================================================================================\n",
            "CONFIGURATION: ORIGINAL\n",
            "Directory: /Users/sarahurbut/Library/CloudStorage/Dropbox/enrollment_predictions_fixedphi_correctedE_vectorized/\n",
            "================================================================================\n",
            "  Pooling 5 batches from enrollment_predictions_fixedphi_correctedE_vectorized...\n",
            "    ✓ Batch 0: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 1: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 2: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 3: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 4: torch.Size([10000, 348, 52])\n",
            "  ✓ Pooled shape: torch.Size([50000, 348, 52])\n",
            "\n",
            "================================================================================\n",
            "EVALUATING: ORIGINAL\n",
            "================================================================================\n",
            "\n",
            "Evaluating static 10-year AUC...\n",
            "\n",
            "Evaluating ASCVD (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.732 (0.726-0.738) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 4333 (8.7%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for ASCVD.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.710, Events = 1446/27107\n",
            "   Male: AUC = 0.714, Events = 2887/22893\n",
            "\n",
            "   ASCVD risk in patients with pre-existing conditions:\n",
            "   RA: AUC = 0.710, Events = 36/248\n",
            "   Breast_Cancer: AUC = 0.657, Events = 48/840\n",
            "\n",
            "Evaluating Diabetes (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.629 (0.624-0.639) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2921 (5.8%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Diabetes.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.624, Events = 1193/27107\n",
            "   Male: AUC = 0.624, Events = 1728/22893\n",
            "\n",
            "Evaluating Atrial_Fib (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.709 (0.702-0.718) (calculated on 49353 individuals)\n",
            "Events (10-Year in Eval Cohort): 1919 (3.8%) (from 50000 individuals)\n",
            "Excluded 647 prevalent cases for Atrial_Fib.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.713, Events = 1041/26933\n",
            "   Male: AUC = 0.712, Events = 852/22420\n",
            "\n",
            "Evaluating CKD (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.703 (0.689-0.708) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 1135 (2.3%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for CKD.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.708, Events = 530/27107\n",
            "   Male: AUC = 0.696, Events = 605/22893\n",
            "\n",
            "Evaluating All_Cancers (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.674 (0.669-0.685) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2521 (5.0%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for All_Cancers.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.640, Events = 785/27107\n",
            "   Male: AUC = 0.676, Events = 1736/22893\n",
            "\n",
            "Evaluating Stroke (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.676 (0.652-0.686) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 692 (1.4%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Stroke.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.673, Events = 313/27107\n",
            "   Male: AUC = 0.673, Events = 379/22893\n",
            "\n",
            "Evaluating Heart_Failure (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.706 (0.692-0.722) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 991 (2.0%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Heart_Failure.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.732, Events = 352/27107\n",
            "   Male: AUC = 0.681, Events = 639/22893\n",
            "\n",
            "Evaluating Pneumonia (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.650 (0.640-0.654) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 1758 (3.5%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Pneumonia.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.651, Events = 773/27107\n",
            "   Male: AUC = 0.644, Events = 985/22893\n",
            "\n",
            "Evaluating COPD (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.665 (0.654-0.672) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2071 (4.1%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for COPD.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.667, Events = 925/27107\n",
            "   Male: AUC = 0.659, Events = 1146/22893\n",
            "\n",
            "Evaluating Osteoporosis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.675 (0.664-0.681) (calculated on 49858 individuals)\n",
            "Events (10-Year in Eval Cohort): 1101 (2.2%) (from 50000 individuals)\n",
            "Excluded 142 prevalent cases for Osteoporosis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.675, Events = 611/26995\n",
            "   Male: AUC = 0.677, Events = 489/22863\n",
            "\n",
            "Evaluating Anemia (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.595 (0.588-0.605) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2676 (5.4%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Anemia.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.568, Events = 1430/27107\n",
            "   Male: AUC = 0.625, Events = 1246/22893\n",
            "\n",
            "Evaluating Colorectal_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.653 (0.641-0.668) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 613 (1.2%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.629, Events = 282/27107\n",
            "   Male: AUC = 0.669, Events = 331/22893\n",
            "\n",
            "Evaluating Breast_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "Filtering for Female: Found 27107 individuals in cohort\n",
            "AUC: 0.548 (0.538-0.564) (calculated on 27107 individuals)\n",
            "Events (10-Year in Eval Cohort): 1098 (4.1%) (from 27107 individuals)\n",
            "Excluded 0 prevalent cases for Breast_Cancer.\n",
            "\n",
            "Evaluating Prostate_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "Filtering for Male: Found 22893 individuals in cohort\n",
            "AUC: 0.681 (0.671-0.693) (calculated on 22640 individuals)\n",
            "Events (10-Year in Eval Cohort): 952 (4.2%) (from 22893 individuals)\n",
            "Excluded 253 prevalent cases for Prostate_Cancer.\n",
            "\n",
            "Evaluating Lung_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.675 (0.662-0.689) (calculated on 49963 individuals)\n",
            "Events (10-Year in Eval Cohort): 432 (0.9%) (from 50000 individuals)\n",
            "Excluded 37 prevalent cases for Lung_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.681, Events = 218/27088\n",
            "   Male: AUC = 0.671, Events = 212/22875\n",
            "\n",
            "Evaluating Bladder_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.716 (0.709-0.729) (calculated on 49870 individuals)\n",
            "Events (10-Year in Eval Cohort): 255 (0.5%) (from 50000 individuals)\n",
            "Excluded 130 prevalent cases for Bladder_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.693, Events = 148/27077\n",
            "   Male: AUC = 0.748, Events = 107/22793\n",
            "\n",
            "Evaluating Secondary_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.607 (0.600-0.620) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 1497 (3.0%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Secondary_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.586, Events = 857/27107\n",
            "   Male: AUC = 0.636, Events = 640/22893\n",
            "\n",
            "Evaluating Depression (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.478 (0.473-0.489) (calculated on 49510 individuals)\n",
            "Events (10-Year in Eval Cohort): 1995 (4.0%) (from 50000 individuals)\n",
            "Excluded 490 prevalent cases for Depression.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.475, Events = 1071/26809\n",
            "   Male: AUC = 0.493, Events = 909/22701\n",
            "\n",
            "Evaluating Anxiety (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.515 (0.507-0.531) (calculated on 49863 individuals)\n",
            "Events (10-Year in Eval Cohort): 1289 (2.6%) (from 50000 individuals)\n",
            "Excluded 137 prevalent cases for Anxiety.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.523, Events = 692/27021\n",
            "   Male: AUC = 0.510, Events = 597/22842\n",
            "\n",
            "Evaluating Bipolar_Disorder (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.449 (0.422-0.471) (calculated on 49925 individuals)\n",
            "Events (10-Year in Eval Cohort): 121 (0.2%) (from 50000 individuals)\n",
            "Excluded 75 prevalent cases for Bipolar_Disorder.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.464, Events = 69/27055\n",
            "   Male: AUC = 0.420, Events = 51/22870\n",
            "\n",
            "Evaluating Rheumatoid_Arthritis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.612 (0.594-0.628) (calculated on 49752 individuals)\n",
            "Events (10-Year in Eval Cohort): 595 (1.2%) (from 50000 individuals)\n",
            "Excluded 248 prevalent cases for Rheumatoid_Arthritis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.617, Events = 314/26913\n",
            "   Male: AUC = 0.609, Events = 279/22839\n",
            "\n",
            "Evaluating Psoriasis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.550 (0.501-0.591) (calculated on 49901 individuals)\n",
            "Events (10-Year in Eval Cohort): 236 (0.5%) (from 50000 individuals)\n",
            "Excluded 99 prevalent cases for Psoriasis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.532, Events = 111/27069\n",
            "   Male: AUC = 0.565, Events = 124/22832\n",
            "\n",
            "Evaluating Ulcerative_Colitis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.572 (0.519-0.604) (calculated on 49750 individuals)\n",
            "Events (10-Year in Eval Cohort): 248 (0.5%) (from 50000 individuals)\n",
            "Excluded 250 prevalent cases for Ulcerative_Colitis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.576, Events = 144/26979\n",
            "   Male: AUC = 0.570, Events = 103/22771\n",
            "\n",
            "Evaluating Crohns_Disease (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.578 (0.547-0.630) (calculated on 49850 individuals)\n",
            "Events (10-Year in Eval Cohort): 136 (0.3%) (from 50000 individuals)\n",
            "Excluded 150 prevalent cases for Crohns_Disease.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.593, Events = 77/27034\n",
            "   Male: AUC = 0.562, Events = 59/22816\n",
            "\n",
            "Evaluating Asthma (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.526 (0.518-0.537) (calculated on 48407 individuals)\n",
            "Events (10-Year in Eval Cohort): 3038 (6.1%) (from 50000 individuals)\n",
            "Excluded 1593 prevalent cases for Asthma.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.544, Events = 1591/26140\n",
            "   Male: AUC = 0.543, Events = 1350/22267\n",
            "\n",
            "Evaluating Parkinsons (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.728 (0.703-0.742) (calculated on 49971 individuals)\n",
            "Events (10-Year in Eval Cohort): 223 (0.4%) (from 50000 individuals)\n",
            "Excluded 29 prevalent cases for Parkinsons.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.740, Events = 124/27095\n",
            "   Male: AUC = 0.713, Events = 99/22876\n",
            "\n",
            "Evaluating Multiple_Sclerosis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.525 (0.475-0.558) (calculated on 49869 individuals)\n",
            "Events (10-Year in Eval Cohort): 97 (0.2%) (from 50000 individuals)\n",
            "Excluded 131 prevalent cases for Multiple_Sclerosis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.517, Events = 61/27009\n",
            "   Male: AUC = 0.542, Events = 36/22860\n",
            "\n",
            "Evaluating Thyroid_Disorders (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.574 (0.566-0.580) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2238 (4.5%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.574, Events = 1792/27107\n",
            "   Male: AUC = 0.561, Events = 446/22893\n",
            "\n",
            "Summary of Results (Prospective 10-Year Outcome, 1-Year Score, Sex-Adjusted):\n",
            "--------------------------------------------------------------------------------\n",
            "Disease Group        AUC                       Events     Rate (%)  \n",
            "--------------------------------------------------------------------------------\n",
            "ASCVD                0.732 (0.726-0.738)       4333       8.7\n",
            "Diabetes             0.629 (0.624-0.639)       2921       5.8\n",
            "Atrial_Fib           0.709 (0.702-0.718)       1919       3.8\n",
            "CKD                  0.703 (0.689-0.708)       1135       2.3\n",
            "All_Cancers          0.674 (0.669-0.685)       2521       5.0\n",
            "Stroke               0.676 (0.652-0.686)       692        1.4\n",
            "Heart_Failure        0.706 (0.692-0.722)       991        2.0\n",
            "Pneumonia            0.650 (0.640-0.654)       1758       3.5\n",
            "COPD                 0.665 (0.654-0.672)       2071       4.1\n",
            "Osteoporosis         0.675 (0.664-0.681)       1101       2.2\n",
            "Anemia               0.595 (0.588-0.605)       2676       5.4\n",
            "Colorectal_Cancer    0.653 (0.641-0.668)       613        1.2\n",
            "Breast_Cancer        0.548 (0.538-0.564)       1098       4.1\n",
            "Prostate_Cancer      0.681 (0.671-0.693)       952        4.2\n",
            "Lung_Cancer          0.675 (0.662-0.689)       432        0.9\n",
            "Bladder_Cancer       0.716 (0.709-0.729)       255        0.5\n",
            "Secondary_Cancer     0.607 (0.600-0.620)       1497       3.0\n",
            "Depression           0.478 (0.473-0.489)       1995       4.0\n",
            "Anxiety              0.515 (0.507-0.531)       1289       2.6\n",
            "Bipolar_Disorder     0.449 (0.422-0.471)       121        0.2\n",
            "Rheumatoid_Arthritis 0.612 (0.594-0.628)       595        1.2\n",
            "Psoriasis            0.550 (0.501-0.591)       236        0.5\n",
            "Ulcerative_Colitis   0.572 (0.519-0.604)       248        0.5\n",
            "Crohns_Disease       0.578 (0.547-0.630)       136        0.3\n",
            "Asthma               0.526 (0.518-0.537)       3038       6.1\n",
            "Parkinsons           0.728 (0.703-0.742)       223        0.4\n",
            "Multiple_Sclerosis   0.525 (0.475-0.558)       97         0.2\n",
            "Thyroid_Disorders    0.574 (0.566-0.580)       2238       4.5\n",
            "--------------------------------------------------------------------------------\n",
            "Evaluating dynamic 1-year AUC...\n",
            "Filtering for 1: Found 22893 individuals in cohort\n",
            "\n",
            "Summary of Results (1-Year Risk, Sex-Adjusted, Offset=0):\n",
            "--------------------------------------------------------------------------------\n",
            "Disease Group        AUC                       Events     Rate (%)   C-index   \n",
            "--------------------------------------------------------------------------------\n",
            "ASCVD                0.873 (0.850-0.888)       397        0.8        N/A\n",
            "Diabetes             0.714 (0.652-0.740)       195        0.4        N/A\n",
            "Atrial_Fib           0.838 (0.785-0.866)       120        0.2        N/A\n",
            "CKD                  0.684 (0.475-0.720)       16         0.0        N/A\n",
            "All_Cancers          0.737 (0.709-0.770)       115        0.2        N/A\n",
            "Stroke               0.658 (0.576-0.730)       30         0.1        N/A\n",
            "Heart_Failure        0.812 (0.792-0.857)       51         0.1        N/A\n",
            "Pneumonia            0.611 (0.567-0.680)       56         0.1        N/A\n",
            "COPD                 0.724 (0.672-0.753)       99         0.2        N/A\n",
            "Osteoporosis         0.786 (0.701-0.822)       44         0.1        N/A\n",
            "Anemia               0.633 (0.584-0.656)       144        0.3        N/A\n",
            "Colorectal_Cancer    0.852 (0.828-0.900)       37         0.1        N/A\n",
            "Breast_Cancer        0.833 (0.803-0.897)       89         0.2        N/A\n",
            "Prostate_Cancer      0.801 (0.767-0.839)       56         0.2        N/A\n",
            "Lung_Cancer          0.744 (0.642-0.848)       11         0.0        N/A\n",
            "Bladder_Cancer       0.822 (0.787-0.883)       9          0.0        N/A\n",
            "Secondary_Cancer     0.598 (0.556-0.647)       51         0.1        N/A\n",
            "Depression           0.668 (0.627-0.726)       62         0.1        N/A\n",
            "Anxiety              0.682 (0.646-0.776)       24         0.0        N/A\n",
            "Bipolar_Disorder     0.715 (0.434-0.963)       4          0.0        N/A\n",
            "Rheumatoid_Arthritis 0.803 (0.712-0.862)       34         0.1        N/A\n",
            "Psoriasis            0.683 (0.578-0.716)       9          0.0        N/A\n",
            "Ulcerative_Colitis   0.937 (0.860-0.979)       17         0.0        N/A\n",
            "Crohns_Disease       0.970 (0.954-0.989)       7          0.0        N/A\n",
            "Asthma               0.666 (0.627-0.700)       251        0.5        N/A\n",
            "Parkinsons           0.767 (0.634-0.839)       10         0.0        N/A\n",
            "Multiple_Sclerosis   0.935 (0.874-0.970)       13         0.0        N/A\n",
            "Thyroid_Disorders    0.658 (0.623-0.716)       137        0.3        N/A\n",
            "--------------------------------------------------------------------------------\n",
            "  ✓ Static 10-year: 28 diseases\n",
            "  ✓ Dynamic 1-year: 28 diseases\n",
            "\n",
            "================================================================================\n",
            "CONFIGURATION: FIXEDGK\n",
            "Directory: /Users/sarahurbut/Library/CloudStorage/Dropbox/enrollment_predictions_fixedphi_fixedgk_vectorized/\n",
            "================================================================================\n",
            "  Pooling 5 batches from enrollment_predictions_fixedphi_fixedgk_vectorized...\n",
            "    ✓ Batch 0: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 1: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 2: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 3: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 4: torch.Size([10000, 348, 52])\n",
            "  ✓ Pooled shape: torch.Size([50000, 348, 52])\n",
            "\n",
            "================================================================================\n",
            "EVALUATING: FIXEDGK\n",
            "================================================================================\n",
            "\n",
            "Evaluating static 10-year AUC...\n",
            "\n",
            "Evaluating ASCVD (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.695 (0.689-0.702) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 4333 (8.7%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for ASCVD.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.692, Events = 1446/27107\n",
            "   Male: AUC = 0.688, Events = 2887/22893\n",
            "\n",
            "   ASCVD risk in patients with pre-existing conditions:\n",
            "   RA: AUC = 0.676, Events = 36/248\n",
            "   Breast_Cancer: AUC = 0.643, Events = 48/840\n",
            "\n",
            "Evaluating Diabetes (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.603 (0.597-0.616) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2921 (5.8%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Diabetes.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.598, Events = 1193/27107\n",
            "   Male: AUC = 0.601, Events = 1728/22893\n",
            "\n",
            "Evaluating Atrial_Fib (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.704 (0.699-0.712) (calculated on 49353 individuals)\n",
            "Events (10-Year in Eval Cohort): 1919 (3.8%) (from 50000 individuals)\n",
            "Excluded 647 prevalent cases for Atrial_Fib.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.708, Events = 1041/26933\n",
            "   Male: AUC = 0.708, Events = 852/22420\n",
            "\n",
            "Evaluating CKD (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.704 (0.691-0.716) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 1135 (2.3%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for CKD.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.709, Events = 530/27107\n",
            "   Male: AUC = 0.697, Events = 605/22893\n",
            "\n",
            "Evaluating All_Cancers (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.669 (0.657-0.676) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2521 (5.0%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for All_Cancers.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.639, Events = 785/27107\n",
            "   Male: AUC = 0.675, Events = 1736/22893\n",
            "\n",
            "Evaluating Stroke (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.675 (0.659-0.693) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 692 (1.4%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Stroke.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.672, Events = 313/27107\n",
            "   Male: AUC = 0.673, Events = 379/22893\n",
            "\n",
            "Evaluating Heart_Failure (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.704 (0.687-0.712) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 991 (2.0%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Heart_Failure.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.732, Events = 352/27107\n",
            "   Male: AUC = 0.680, Events = 639/22893\n",
            "\n",
            "Evaluating Pneumonia (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.649 (0.643-0.655) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 1758 (3.5%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Pneumonia.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.649, Events = 773/27107\n",
            "   Male: AUC = 0.645, Events = 985/22893\n",
            "\n",
            "Evaluating COPD (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.663 (0.655-0.671) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2071 (4.1%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for COPD.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.666, Events = 925/27107\n",
            "   Male: AUC = 0.657, Events = 1146/22893\n",
            "\n",
            "Evaluating Osteoporosis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.669 (0.653-0.682) (calculated on 49858 individuals)\n",
            "Events (10-Year in Eval Cohort): 1101 (2.2%) (from 50000 individuals)\n",
            "Excluded 142 prevalent cases for Osteoporosis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.669, Events = 611/26995\n",
            "   Male: AUC = 0.670, Events = 489/22863\n",
            "\n",
            "Evaluating Anemia (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.595 (0.588-0.603) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2676 (5.4%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Anemia.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.567, Events = 1430/27107\n",
            "   Male: AUC = 0.626, Events = 1246/22893\n",
            "\n",
            "Evaluating Colorectal_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.647 (0.624-0.671) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 613 (1.2%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.624, Events = 282/27107\n",
            "   Male: AUC = 0.663, Events = 331/22893\n",
            "\n",
            "Evaluating Breast_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "Filtering for Female: Found 27107 individuals in cohort\n",
            "AUC: 0.541 (0.527-0.555) (calculated on 27107 individuals)\n",
            "Events (10-Year in Eval Cohort): 1098 (4.1%) (from 27107 individuals)\n",
            "Excluded 0 prevalent cases for Breast_Cancer.\n",
            "\n",
            "Evaluating Prostate_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "Filtering for Male: Found 22893 individuals in cohort\n",
            "AUC: 0.678 (0.667-0.684) (calculated on 22640 individuals)\n",
            "Events (10-Year in Eval Cohort): 952 (4.2%) (from 22893 individuals)\n",
            "Excluded 253 prevalent cases for Prostate_Cancer.\n",
            "\n",
            "Evaluating Lung_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.673 (0.663-0.693) (calculated on 49963 individuals)\n",
            "Events (10-Year in Eval Cohort): 432 (0.9%) (from 50000 individuals)\n",
            "Excluded 37 prevalent cases for Lung_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.679, Events = 218/27088\n",
            "   Male: AUC = 0.671, Events = 212/22875\n",
            "\n",
            "Evaluating Bladder_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.705 (0.685-0.725) (calculated on 49870 individuals)\n",
            "Events (10-Year in Eval Cohort): 255 (0.5%) (from 50000 individuals)\n",
            "Excluded 130 prevalent cases for Bladder_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.681, Events = 148/27077\n",
            "   Male: AUC = 0.739, Events = 107/22793\n",
            "\n",
            "Evaluating Secondary_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.604 (0.594-0.615) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 1497 (3.0%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Secondary_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.583, Events = 857/27107\n",
            "   Male: AUC = 0.635, Events = 640/22893\n",
            "\n",
            "Evaluating Depression (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.471 (0.458-0.483) (calculated on 49510 individuals)\n",
            "Events (10-Year in Eval Cohort): 1995 (4.0%) (from 50000 individuals)\n",
            "Excluded 490 prevalent cases for Depression.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.467, Events = 1071/26809\n",
            "   Male: AUC = 0.487, Events = 909/22701\n",
            "\n",
            "Evaluating Anxiety (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.509 (0.503-0.524) (calculated on 49863 individuals)\n",
            "Events (10-Year in Eval Cohort): 1289 (2.6%) (from 50000 individuals)\n",
            "Excluded 137 prevalent cases for Anxiety.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.518, Events = 692/27021\n",
            "   Male: AUC = 0.502, Events = 597/22842\n",
            "\n",
            "Evaluating Bipolar_Disorder (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.454 (0.421-0.530) (calculated on 49925 individuals)\n",
            "Events (10-Year in Eval Cohort): 121 (0.2%) (from 50000 individuals)\n",
            "Excluded 75 prevalent cases for Bipolar_Disorder.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.481, Events = 69/27055\n",
            "   Male: AUC = 0.410, Events = 51/22870\n",
            "\n",
            "Evaluating Rheumatoid_Arthritis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.606 (0.584-0.618) (calculated on 49752 individuals)\n",
            "Events (10-Year in Eval Cohort): 595 (1.2%) (from 50000 individuals)\n",
            "Excluded 248 prevalent cases for Rheumatoid_Arthritis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.608, Events = 314/26913\n",
            "   Male: AUC = 0.605, Events = 279/22839\n",
            "\n",
            "Evaluating Psoriasis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.549 (0.513-0.582) (calculated on 49901 individuals)\n",
            "Events (10-Year in Eval Cohort): 236 (0.5%) (from 50000 individuals)\n",
            "Excluded 99 prevalent cases for Psoriasis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.537, Events = 111/27069\n",
            "   Male: AUC = 0.558, Events = 124/22832\n",
            "\n",
            "Evaluating Ulcerative_Colitis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.567 (0.555-0.616) (calculated on 49750 individuals)\n",
            "Events (10-Year in Eval Cohort): 248 (0.5%) (from 50000 individuals)\n",
            "Excluded 250 prevalent cases for Ulcerative_Colitis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.569, Events = 144/26979\n",
            "   Male: AUC = 0.569, Events = 103/22771\n",
            "\n",
            "Evaluating Crohns_Disease (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.555 (0.544-0.575) (calculated on 49850 individuals)\n",
            "Events (10-Year in Eval Cohort): 136 (0.3%) (from 50000 individuals)\n",
            "Excluded 150 prevalent cases for Crohns_Disease.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.571, Events = 77/27034\n",
            "   Male: AUC = 0.538, Events = 59/22816\n",
            "\n",
            "Evaluating Asthma (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.519 (0.510-0.527) (calculated on 48407 individuals)\n",
            "Events (10-Year in Eval Cohort): 3038 (6.1%) (from 50000 individuals)\n",
            "Excluded 1593 prevalent cases for Asthma.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.538, Events = 1591/26140\n",
            "   Male: AUC = 0.535, Events = 1350/22267\n",
            "\n",
            "Evaluating Parkinsons (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.731 (0.712-0.759) (calculated on 49971 individuals)\n",
            "Events (10-Year in Eval Cohort): 223 (0.4%) (from 50000 individuals)\n",
            "Excluded 29 prevalent cases for Parkinsons.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.744, Events = 124/27095\n",
            "   Male: AUC = 0.715, Events = 99/22876\n",
            "\n",
            "Evaluating Multiple_Sclerosis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.546 (0.482-0.591) (calculated on 49869 individuals)\n",
            "Events (10-Year in Eval Cohort): 97 (0.2%) (from 50000 individuals)\n",
            "Excluded 131 prevalent cases for Multiple_Sclerosis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.528, Events = 61/27009\n",
            "   Male: AUC = 0.579, Events = 36/22860\n",
            "\n",
            "Evaluating Thyroid_Disorders (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.563 (0.552-0.571) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2238 (4.5%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.572, Events = 1792/27107\n",
            "   Male: AUC = 0.557, Events = 446/22893\n",
            "\n",
            "Summary of Results (Prospective 10-Year Outcome, 1-Year Score, Sex-Adjusted):\n",
            "--------------------------------------------------------------------------------\n",
            "Disease Group        AUC                       Events     Rate (%)  \n",
            "--------------------------------------------------------------------------------\n",
            "ASCVD                0.695 (0.689-0.702)       4333       8.7\n",
            "Diabetes             0.603 (0.597-0.616)       2921       5.8\n",
            "Atrial_Fib           0.704 (0.699-0.712)       1919       3.8\n",
            "CKD                  0.704 (0.691-0.716)       1135       2.3\n",
            "All_Cancers          0.669 (0.657-0.676)       2521       5.0\n",
            "Stroke               0.675 (0.659-0.693)       692        1.4\n",
            "Heart_Failure        0.704 (0.687-0.712)       991        2.0\n",
            "Pneumonia            0.649 (0.643-0.655)       1758       3.5\n",
            "COPD                 0.663 (0.655-0.671)       2071       4.1\n",
            "Osteoporosis         0.669 (0.653-0.682)       1101       2.2\n",
            "Anemia               0.595 (0.588-0.603)       2676       5.4\n",
            "Colorectal_Cancer    0.647 (0.624-0.671)       613        1.2\n",
            "Breast_Cancer        0.541 (0.527-0.555)       1098       4.1\n",
            "Prostate_Cancer      0.678 (0.667-0.684)       952        4.2\n",
            "Lung_Cancer          0.673 (0.663-0.693)       432        0.9\n",
            "Bladder_Cancer       0.705 (0.685-0.725)       255        0.5\n",
            "Secondary_Cancer     0.604 (0.594-0.615)       1497       3.0\n",
            "Depression           0.471 (0.458-0.483)       1995       4.0\n",
            "Anxiety              0.509 (0.503-0.524)       1289       2.6\n",
            "Bipolar_Disorder     0.454 (0.421-0.530)       121        0.2\n",
            "Rheumatoid_Arthritis 0.606 (0.584-0.618)       595        1.2\n",
            "Psoriasis            0.549 (0.513-0.582)       236        0.5\n",
            "Ulcerative_Colitis   0.567 (0.555-0.616)       248        0.5\n",
            "Crohns_Disease       0.555 (0.544-0.575)       136        0.3\n",
            "Asthma               0.519 (0.510-0.527)       3038       6.1\n",
            "Parkinsons           0.731 (0.712-0.759)       223        0.4\n",
            "Multiple_Sclerosis   0.546 (0.482-0.591)       97         0.2\n",
            "Thyroid_Disorders    0.563 (0.552-0.571)       2238       4.5\n",
            "--------------------------------------------------------------------------------\n",
            "Evaluating dynamic 1-year AUC...\n",
            "Filtering for 1: Found 22893 individuals in cohort\n",
            "\n",
            "Summary of Results (1-Year Risk, Sex-Adjusted, Offset=0):\n",
            "--------------------------------------------------------------------------------\n",
            "Disease Group        AUC                       Events     Rate (%)   C-index   \n",
            "--------------------------------------------------------------------------------\n",
            "ASCVD                0.870 (0.842-0.891)       397        0.8        N/A\n",
            "Diabetes             0.685 (0.665-0.697)       195        0.4        N/A\n",
            "Atrial_Fib           0.828 (0.786-0.857)       120        0.2        N/A\n",
            "CKD                  0.680 (0.572-0.820)       16         0.0        N/A\n",
            "All_Cancers          0.731 (0.702-0.767)       115        0.2        N/A\n",
            "Stroke               0.659 (0.598-0.704)       30         0.1        N/A\n",
            "Heart_Failure        0.804 (0.753-0.871)       51         0.1        N/A\n",
            "Pneumonia            0.609 (0.560-0.636)       56         0.1        N/A\n",
            "COPD                 0.727 (0.679-0.755)       99         0.2        N/A\n",
            "Osteoporosis         0.782 (0.697-0.819)       44         0.1        N/A\n",
            "Anemia               0.635 (0.593-0.680)       144        0.3        N/A\n",
            "Colorectal_Cancer    0.847 (0.832-0.877)       37         0.1        N/A\n",
            "Breast_Cancer        0.841 (0.781-0.888)       89         0.2        N/A\n",
            "Prostate_Cancer      0.799 (0.749-0.846)       56         0.2        N/A\n",
            "Lung_Cancer          0.748 (0.649-0.895)       11         0.0        N/A\n",
            "Bladder_Cancer       0.827 (0.712-0.914)       9          0.0        N/A\n",
            "Secondary_Cancer     0.598 (0.542-0.646)       51         0.1        N/A\n",
            "Depression           0.665 (0.588-0.722)       62         0.1        N/A\n",
            "Anxiety              0.680 (0.586-0.790)       24         0.0        N/A\n",
            "Bipolar_Disorder     0.869 (0.735-0.957)       4          0.0        N/A\n",
            "Rheumatoid_Arthritis 0.801 (0.707-0.821)       34         0.1        N/A\n",
            "Psoriasis            0.722 (0.630-0.868)       9          0.0        N/A\n",
            "Ulcerative_Colitis   0.943 (0.914-0.981)       17         0.0        N/A\n",
            "Crohns_Disease       0.966 (0.953-0.970)       7          0.0        N/A\n",
            "Asthma               0.663 (0.647-0.686)       251        0.5        N/A\n",
            "Parkinsons           0.783 (0.724-0.895)       10         0.0        N/A\n",
            "Multiple_Sclerosis   0.951 (0.929-0.958)       13         0.0        N/A\n",
            "Thyroid_Disorders    0.653 (0.591-0.683)       137        0.3        N/A\n",
            "--------------------------------------------------------------------------------\n",
            "  ✓ Static 10-year: 28 diseases\n",
            "  ✓ Dynamic 1-year: 28 diseases\n",
            "\n",
            "================================================================================\n",
            "CONFIGURATION: FIXEDGK_NOLR\n",
            "Directory: /Users/sarahurbut/Library/CloudStorage/Dropbox/enrollment_predictions_fixedphi_fixedgk_nolr_vectorized/\n",
            "================================================================================\n",
            "  Pooling 5 batches from enrollment_predictions_fixedphi_fixedgk_nolr_vectorized...\n",
            "    ✓ Batch 0: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 1: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 2: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 3: torch.Size([10000, 348, 52])\n",
            "    ✓ Batch 4: torch.Size([10000, 348, 52])\n",
            "  ✓ Pooled shape: torch.Size([50000, 348, 52])\n",
            "\n",
            "================================================================================\n",
            "EVALUATING: FIXEDGK_NOLR\n",
            "================================================================================\n",
            "\n",
            "Evaluating static 10-year AUC...\n",
            "\n",
            "Evaluating ASCVD (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.730 (0.721-0.733) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 4333 (8.7%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for ASCVD.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.705, Events = 1446/27107\n",
            "   Male: AUC = 0.711, Events = 2887/22893\n",
            "\n",
            "   ASCVD risk in patients with pre-existing conditions:\n",
            "   RA: AUC = 0.713, Events = 36/248\n",
            "   Breast_Cancer: AUC = 0.666, Events = 48/840\n",
            "\n",
            "Evaluating Diabetes (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.629 (0.622-0.635) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2921 (5.8%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Diabetes.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.622, Events = 1193/27107\n",
            "   Male: AUC = 0.625, Events = 1728/22893\n",
            "\n",
            "Evaluating Atrial_Fib (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.710 (0.697-0.716) (calculated on 49353 individuals)\n",
            "Events (10-Year in Eval Cohort): 1919 (3.8%) (from 50000 individuals)\n",
            "Excluded 647 prevalent cases for Atrial_Fib.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.714, Events = 1041/26933\n",
            "   Male: AUC = 0.713, Events = 852/22420\n",
            "\n",
            "Evaluating CKD (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.702 (0.701-0.716) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 1135 (2.3%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for CKD.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.708, Events = 530/27107\n",
            "   Male: AUC = 0.695, Events = 605/22893\n",
            "\n",
            "Evaluating All_Cancers (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.674 (0.669-0.680) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2521 (5.0%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for All_Cancers.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.639, Events = 785/27107\n",
            "   Male: AUC = 0.676, Events = 1736/22893\n",
            "\n",
            "Evaluating Stroke (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.675 (0.654-0.694) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 692 (1.4%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Stroke.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.672, Events = 313/27107\n",
            "   Male: AUC = 0.673, Events = 379/22893\n",
            "\n",
            "Evaluating Heart_Failure (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.705 (0.692-0.715) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 991 (2.0%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Heart_Failure.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.732, Events = 352/27107\n",
            "   Male: AUC = 0.679, Events = 639/22893\n",
            "\n",
            "Evaluating Pneumonia (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.650 (0.635-0.659) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 1758 (3.5%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Pneumonia.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.650, Events = 773/27107\n",
            "   Male: AUC = 0.644, Events = 985/22893\n",
            "\n",
            "Evaluating COPD (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.664 (0.660-0.673) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2071 (4.1%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for COPD.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.667, Events = 925/27107\n",
            "   Male: AUC = 0.657, Events = 1146/22893\n",
            "\n",
            "Evaluating Osteoporosis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.676 (0.661-0.685) (calculated on 49858 individuals)\n",
            "Events (10-Year in Eval Cohort): 1101 (2.2%) (from 50000 individuals)\n",
            "Excluded 142 prevalent cases for Osteoporosis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.676, Events = 611/26995\n",
            "   Male: AUC = 0.677, Events = 489/22863\n",
            "\n",
            "Evaluating Anemia (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.594 (0.585-0.599) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2676 (5.4%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Anemia.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.567, Events = 1430/27107\n",
            "   Male: AUC = 0.624, Events = 1246/22893\n",
            "\n",
            "Evaluating Colorectal_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.652 (0.634-0.663) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 613 (1.2%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.629, Events = 282/27107\n",
            "   Male: AUC = 0.667, Events = 331/22893\n",
            "\n",
            "Evaluating Breast_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "Filtering for Female: Found 27107 individuals in cohort\n",
            "AUC: 0.545 (0.533-0.555) (calculated on 27107 individuals)\n",
            "Events (10-Year in Eval Cohort): 1098 (4.1%) (from 27107 individuals)\n",
            "Excluded 0 prevalent cases for Breast_Cancer.\n",
            "\n",
            "Evaluating Prostate_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "Filtering for Male: Found 22893 individuals in cohort\n",
            "AUC: 0.683 (0.672-0.699) (calculated on 22640 individuals)\n",
            "Events (10-Year in Eval Cohort): 952 (4.2%) (from 22893 individuals)\n",
            "Excluded 253 prevalent cases for Prostate_Cancer.\n",
            "\n",
            "Evaluating Lung_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.673 (0.666-0.697) (calculated on 49963 individuals)\n",
            "Events (10-Year in Eval Cohort): 432 (0.9%) (from 50000 individuals)\n",
            "Excluded 37 prevalent cases for Lung_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.679, Events = 218/27088\n",
            "   Male: AUC = 0.671, Events = 212/22875\n",
            "\n",
            "Evaluating Bladder_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.714 (0.693-0.742) (calculated on 49870 individuals)\n",
            "Events (10-Year in Eval Cohort): 255 (0.5%) (from 50000 individuals)\n",
            "Excluded 130 prevalent cases for Bladder_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.691, Events = 148/27077\n",
            "   Male: AUC = 0.747, Events = 107/22793\n",
            "\n",
            "Evaluating Secondary_Cancer (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.605 (0.598-0.615) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 1497 (3.0%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Secondary_Cancer.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.584, Events = 857/27107\n",
            "   Male: AUC = 0.635, Events = 640/22893\n",
            "\n",
            "Evaluating Depression (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.478 (0.462-0.493) (calculated on 49510 individuals)\n",
            "Events (10-Year in Eval Cohort): 1995 (4.0%) (from 50000 individuals)\n",
            "Excluded 490 prevalent cases for Depression.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.474, Events = 1071/26809\n",
            "   Male: AUC = 0.494, Events = 909/22701\n",
            "\n",
            "Evaluating Anxiety (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.514 (0.502-0.528) (calculated on 49863 individuals)\n",
            "Events (10-Year in Eval Cohort): 1289 (2.6%) (from 50000 individuals)\n",
            "Excluded 137 prevalent cases for Anxiety.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.521, Events = 692/27021\n",
            "   Male: AUC = 0.508, Events = 597/22842\n",
            "\n",
            "Evaluating Bipolar_Disorder (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.458 (0.402-0.498) (calculated on 49925 individuals)\n",
            "Events (10-Year in Eval Cohort): 121 (0.2%) (from 50000 individuals)\n",
            "Excluded 75 prevalent cases for Bipolar_Disorder.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.481, Events = 69/27055\n",
            "   Male: AUC = 0.419, Events = 51/22870\n",
            "\n",
            "Evaluating Rheumatoid_Arthritis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.611 (0.603-0.624) (calculated on 49752 individuals)\n",
            "Events (10-Year in Eval Cohort): 595 (1.2%) (from 50000 individuals)\n",
            "Excluded 248 prevalent cases for Rheumatoid_Arthritis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.615, Events = 314/26913\n",
            "   Male: AUC = 0.610, Events = 279/22839\n",
            "\n",
            "Evaluating Psoriasis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.549 (0.516-0.598) (calculated on 49901 individuals)\n",
            "Events (10-Year in Eval Cohort): 236 (0.5%) (from 50000 individuals)\n",
            "Excluded 99 prevalent cases for Psoriasis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.538, Events = 111/27069\n",
            "   Male: AUC = 0.558, Events = 124/22832\n",
            "\n",
            "Evaluating Ulcerative_Colitis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.570 (0.525-0.602) (calculated on 49750 individuals)\n",
            "Events (10-Year in Eval Cohort): 248 (0.5%) (from 50000 individuals)\n",
            "Excluded 250 prevalent cases for Ulcerative_Colitis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.573, Events = 144/26979\n",
            "   Male: AUC = 0.571, Events = 103/22771\n",
            "\n",
            "Evaluating Crohns_Disease (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.565 (0.534-0.628) (calculated on 49850 individuals)\n",
            "Events (10-Year in Eval Cohort): 136 (0.3%) (from 50000 individuals)\n",
            "Excluded 150 prevalent cases for Crohns_Disease.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.584, Events = 77/27034\n",
            "   Male: AUC = 0.542, Events = 59/22816\n",
            "\n",
            "Evaluating Asthma (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.527 (0.519-0.534) (calculated on 48407 individuals)\n",
            "Events (10-Year in Eval Cohort): 3038 (6.1%) (from 50000 individuals)\n",
            "Excluded 1593 prevalent cases for Asthma.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.546, Events = 1591/26140\n",
            "   Male: AUC = 0.542, Events = 1350/22267\n",
            "\n",
            "Evaluating Parkinsons (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.731 (0.711-0.758) (calculated on 49971 individuals)\n",
            "Events (10-Year in Eval Cohort): 223 (0.4%) (from 50000 individuals)\n",
            "Excluded 29 prevalent cases for Parkinsons.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.744, Events = 124/27095\n",
            "   Male: AUC = 0.716, Events = 99/22876\n",
            "\n",
            "Evaluating Multiple_Sclerosis (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.549 (0.510-0.633) (calculated on 49869 individuals)\n",
            "Events (10-Year in Eval Cohort): 97 (0.2%) (from 50000 individuals)\n",
            "Excluded 131 prevalent cases for Multiple_Sclerosis.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.530, Events = 61/27009\n",
            "   Male: AUC = 0.582, Events = 36/22860\n",
            "\n",
            "Evaluating Thyroid_Disorders (10-Year Outcome, 1-Year Score)...\n",
            "AUC: 0.573 (0.563-0.595) (calculated on 50000 individuals)\n",
            "Events (10-Year in Eval Cohort): 2238 (4.5%) (from 50000 individuals)\n",
            "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
            "\n",
            "   Sex-stratified analysis:\n",
            "   Female: AUC = 0.573, Events = 1792/27107\n",
            "   Male: AUC = 0.560, Events = 446/22893\n",
            "\n",
            "Summary of Results (Prospective 10-Year Outcome, 1-Year Score, Sex-Adjusted):\n",
            "--------------------------------------------------------------------------------\n",
            "Disease Group        AUC                       Events     Rate (%)  \n",
            "--------------------------------------------------------------------------------\n",
            "ASCVD                0.730 (0.721-0.733)       4333       8.7\n",
            "Diabetes             0.629 (0.622-0.635)       2921       5.8\n",
            "Atrial_Fib           0.710 (0.697-0.716)       1919       3.8\n",
            "CKD                  0.702 (0.701-0.716)       1135       2.3\n",
            "All_Cancers          0.674 (0.669-0.680)       2521       5.0\n",
            "Stroke               0.675 (0.654-0.694)       692        1.4\n",
            "Heart_Failure        0.705 (0.692-0.715)       991        2.0\n",
            "Pneumonia            0.650 (0.635-0.659)       1758       3.5\n",
            "COPD                 0.664 (0.660-0.673)       2071       4.1\n",
            "Osteoporosis         0.676 (0.661-0.685)       1101       2.2\n",
            "Anemia               0.594 (0.585-0.599)       2676       5.4\n",
            "Colorectal_Cancer    0.652 (0.634-0.663)       613        1.2\n",
            "Breast_Cancer        0.545 (0.533-0.555)       1098       4.1\n",
            "Prostate_Cancer      0.683 (0.672-0.699)       952        4.2\n",
            "Lung_Cancer          0.673 (0.666-0.697)       432        0.9\n",
            "Bladder_Cancer       0.714 (0.693-0.742)       255        0.5\n",
            "Secondary_Cancer     0.605 (0.598-0.615)       1497       3.0\n",
            "Depression           0.478 (0.462-0.493)       1995       4.0\n",
            "Anxiety              0.514 (0.502-0.528)       1289       2.6\n",
            "Bipolar_Disorder     0.458 (0.402-0.498)       121        0.2\n",
            "Rheumatoid_Arthritis 0.611 (0.603-0.624)       595        1.2\n",
            "Psoriasis            0.549 (0.516-0.598)       236        0.5\n",
            "Ulcerative_Colitis   0.570 (0.525-0.602)       248        0.5\n",
            "Crohns_Disease       0.565 (0.534-0.628)       136        0.3\n",
            "Asthma               0.527 (0.519-0.534)       3038       6.1\n",
            "Parkinsons           0.731 (0.711-0.758)       223        0.4\n",
            "Multiple_Sclerosis   0.549 (0.510-0.633)       97         0.2\n",
            "Thyroid_Disorders    0.573 (0.563-0.595)       2238       4.5\n",
            "--------------------------------------------------------------------------------\n",
            "Evaluating dynamic 1-year AUC...\n",
            "Filtering for 1: Found 22893 individuals in cohort\n",
            "\n",
            "Summary of Results (1-Year Risk, Sex-Adjusted, Offset=0):\n",
            "--------------------------------------------------------------------------------\n",
            "Disease Group        AUC                       Events     Rate (%)   C-index   \n",
            "--------------------------------------------------------------------------------\n",
            "ASCVD                0.872 (0.851-0.883)       397        0.8        N/A\n",
            "Diabetes             0.712 (0.682-0.748)       195        0.4        N/A\n",
            "Atrial_Fib           0.833 (0.800-0.854)       120        0.2        N/A\n",
            "CKD                  0.676 (0.537-0.778)       16         0.0        N/A\n",
            "All_Cancers          0.738 (0.702-0.773)       115        0.2        N/A\n",
            "Stroke               0.659 (0.634-0.705)       30         0.1        N/A\n",
            "Heart_Failure        0.805 (0.762-0.841)       51         0.1        N/A\n",
            "Pneumonia            0.610 (0.567-0.662)       56         0.1        N/A\n",
            "COPD                 0.727 (0.671-0.752)       99         0.2        N/A\n",
            "Osteoporosis         0.788 (0.698-0.848)       44         0.1        N/A\n",
            "Anemia               0.633 (0.605-0.672)       144        0.3        N/A\n",
            "Colorectal_Cancer    0.853 (0.812-0.900)       37         0.1        N/A\n",
            "Breast_Cancer        0.846 (0.800-0.911)       89         0.2        N/A\n",
            "Prostate_Cancer      0.806 (0.785-0.848)       56         0.2        N/A\n",
            "Lung_Cancer          0.749 (0.610-0.839)       11         0.0        N/A\n",
            "Bladder_Cancer       0.831 (0.604-0.860)       9          0.0        N/A\n",
            "Secondary_Cancer     0.600 (0.566-0.624)       51         0.1        N/A\n",
            "Depression           0.673 (0.582-0.702)       62         0.1        N/A\n",
            "Anxiety              0.679 (0.496-0.742)       24         0.0        N/A\n",
            "Bipolar_Disorder     0.849 (0.800-0.983)       4          0.0        N/A\n",
            "Rheumatoid_Arthritis 0.802 (0.772-0.866)       34         0.1        N/A\n",
            "Psoriasis            0.718 (0.624-0.793)       9          0.0        N/A\n",
            "Ulcerative_Colitis   0.932 (0.913-0.965)       17         0.0        N/A\n",
            "Crohns_Disease       0.967 (0.960-0.975)       7          0.0        N/A\n",
            "Asthma               0.668 (0.631-0.680)       251        0.5        N/A\n",
            "Parkinsons           0.790 (0.681-0.927)       10         0.0        N/A\n",
            "Multiple_Sclerosis   0.948 (0.935-0.954)       13         0.0        N/A\n",
            "Thyroid_Disorders    0.660 (0.617-0.682)       137        0.3        N/A\n",
            "--------------------------------------------------------------------------------\n",
            "  ✓ Static 10-year: 28 diseases\n",
            "  ✓ Dynamic 1-year: 28 diseases\n",
            "\n",
            "================================================================================\n",
            "SUMMARY\n",
            "================================================================================\n",
            "Evaluated 5 configurations\n",
            "Static 10-year AUC: 140 disease-config combinations\n",
            "Dynamic 1-year AUC: 140 disease-config combinations\n",
            "\n",
            "Results saved to:\n",
            "  - /Users/sarahurbut/aladynoulli2/pyScripts/dec_6_revision/new_notebooks/results/all_5_configs_5batches_static_10yr_auc_results.csv\n",
            "  - /Users/sarahurbut/aladynoulli2/pyScripts/dec_6_revision/new_notebooks/results/all_5_configs_5batches_dynamic_1yr_auc_results.csv\n",
            "================================================================================\n",
            "COMPLETED\n",
            "================================================================================\n"
          ]
        }
      ],
      "source": [
        "%run evaluate_all_4_configs_5batches_auc.py --n_bootstraps 10"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 4,
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "================================================================================\n",
            "STATIC 10-YEAR AUC RESULTS\n",
            "================================================================================\n",
            "\n",
            "AUC by Disease and Method:\n",
            "                      Original\\n(free γ, free κ)  Fixed κ\\n(free γ)  Fixed γ\\n(free κ)  Fixed γκ\\n(regularized)  Fixed γκ\\n(unregularized)\n",
            "disease                                                                                                                                   \n",
            "ASCVD                                      0.732              0.732              0.695                    0.695                      0.730\n",
            "All_Cancers                                0.674              0.674              0.669                    0.669                      0.674\n",
            "Anemia                                     0.595              0.595              0.595                    0.595                      0.594\n",
            "Anxiety                                    0.515              0.515              0.509                    0.509                      0.514\n",
            "Asthma                                     0.526              0.526              0.519                    0.519                      0.527\n",
            "Atrial_Fib                                 0.709              0.709              0.704                    0.704                      0.710\n",
            "Bipolar_Disorder                           0.449              0.451              0.452                    0.454                      0.458\n",
            "Bladder_Cancer                             0.716              0.716              0.704                    0.705                      0.714\n",
            "Breast_Cancer                              0.548              0.548              0.542                    0.541                      0.545\n",
            "CKD                                        0.703              0.703              0.705                    0.704                      0.702\n",
            "COPD                                       0.665              0.665              0.664                    0.663                      0.664\n",
            "Colorectal_Cancer                          0.653              0.653              0.647                    0.647                      0.652\n",
            "Crohns_Disease                             0.578              0.577              0.557                    0.555                      0.565\n",
            "Depression                                 0.478              0.478              0.471                    0.471                      0.478\n",
            "Diabetes                                   0.629              0.629              0.603                    0.603                      0.629\n",
            "Heart_Failure                              0.706              0.705              0.704                    0.704                      0.705\n",
            "Lung_Cancer                                0.675              0.675              0.673                    0.673                      0.673\n",
            "Multiple_Sclerosis                         0.525              0.529              0.542                    0.546                      0.549\n",
            "Osteoporosis                               0.675              0.675              0.669                    0.669                      0.676\n",
            "Parkinsons                                 0.728              0.728              0.731                    0.731                      0.731\n",
            "Pneumonia                                  0.650              0.650              0.649                    0.649                      0.650\n",
            "Prostate_Cancer                            0.681              0.681              0.678                    0.678                      0.683\n",
            "Psoriasis                                  0.550              0.550              0.549                    0.549                      0.549\n",
            "Rheumatoid_Arthritis                       0.612              0.611              0.606                    0.606                      0.611\n",
            "Secondary_Cancer                           0.607              0.607              0.605                    0.604                      0.605\n",
            "Stroke                                     0.676              0.676              0.675                    0.675                      0.675\n",
            "Thyroid_Disorders                          0.574              0.574              0.563                    0.563                      0.573\n",
            "Ulcerative_Colitis                         0.572              0.572              0.568                    0.567                      0.570\n",
            "\n",
            "================================================================================\n",
            "DIFFERENCES FROM ORIGINAL (Original - Fixed)\n",
            "================================================================================\n",
            "                      Fixed κ\\n(free γ)  Fixed γ\\n(free κ)  Fixed γκ\\n(regularized)  Fixed γκ\\n(unregularized)\n",
            "disease                                                                                                       \n",
            "ASCVD                             0.000              0.037                    0.037                      0.002\n",
            "All_Cancers                       0.000              0.005                    0.005                      0.000\n",
            "Anemia                            0.000              0.000                    0.000                      0.001\n",
            "Anxiety                           0.000              0.006                    0.006                      0.001\n",
            "Asthma                            0.000              0.007                    0.007                     -0.001\n",
            "Atrial_Fib                        0.000              0.005                    0.005                     -0.001\n",
            "Bipolar_Disorder                 -0.002             -0.003                   -0.005                     -0.009\n",
            "Bladder_Cancer                    0.000              0.012                    0.011                      0.002\n",
            "Breast_Cancer                     0.000              0.006                    0.007                      0.003\n",
            "CKD                               0.000             -0.002                   -0.001                      0.001\n",
            "COPD                              0.000              0.001                    0.002                      0.001\n",
            "Colorectal_Cancer                 0.000              0.006                    0.006                      0.001\n",
            "Crohns_Disease                    0.001              0.021                    0.023                      0.013\n",
            "Depression                        0.000              0.007                    0.007                      0.000\n",
            "Diabetes                          0.000              0.026                    0.026                      0.000\n",
            "Heart_Failure                     0.001              0.002                    0.002                      0.001\n",
            "Lung_Cancer                       0.000              0.002                    0.002                      0.002\n",
            "Multiple_Sclerosis               -0.004             -0.017                   -0.021                     -0.024\n",
            "Osteoporosis                      0.000              0.006                    0.006                     -0.001\n",
            "Parkinsons                        0.000             -0.003                   -0.003                     -0.003\n",
            "Pneumonia                         0.000              0.001                    0.001                      0.000\n",
            "Prostate_Cancer                   0.000              0.003                    0.003                     -0.002\n",
            "Psoriasis                         0.000              0.001                    0.001                      0.001\n",
            "Rheumatoid_Arthritis              0.001              0.006                    0.006                      0.001\n",
            "Secondary_Cancer                  0.000              0.002                    0.003                      0.002\n",
            "Stroke                            0.000              0.001                    0.001                      0.001\n",
            "Thyroid_Disorders                 0.000              0.011                    0.011                      0.001\n",
            "Ulcerative_Colitis                0.000              0.004                    0.005                      0.002\n",
            "\n",
            "✓ Saved wide format to: /Users/sarahurbut/aladynoulli2/pyScripts/dec_6_revision/new_notebooks/results/all_5_configs_5batches_static_10yr_auc_results_wide.csv\n",
            "\n",
            "================================================================================\n",
            "DYNAMIC 1-YEAR AUC RESULTS\n",
            "================================================================================\n",
            "\n",
            "AUC by Disease and Method:\n",
            "                      Original\\n(free γ, free κ)  Fixed κ\\n(free γ)  Fixed γ\\n(free κ)  Fixed γκ\\n(regularized)  Fixed γκ\\n(unregularized)\n",
            "disease                                                                                                                                   \n",
            "ASCVD                                      0.873              0.873              0.870                    0.870                      0.872\n",
            "All_Cancers                                0.737              0.737              0.731                    0.731                      0.738\n",
            "Anemia                                     0.633              0.632              0.636                    0.635                      0.633\n",
            "Anxiety                                    0.682              0.684              0.679                    0.680                      0.679\n",
            "Asthma                                     0.666              0.666              0.663                    0.663                      0.668\n",
            "Atrial_Fib                                 0.838              0.837              0.828                    0.828                      0.833\n",
            "Bipolar_Disorder                           0.715              0.734              0.847                    0.869                      0.849\n",
            "Bladder_Cancer                             0.822              0.824              0.825                    0.827                      0.831\n",
            "Breast_Cancer                              0.833              0.834              0.840                    0.841                      0.846\n",
            "CKD                                        0.684              0.683              0.680                    0.680                      0.676\n",
            "COPD                                       0.724              0.725              0.726                    0.727                      0.727\n",
            "Colorectal_Cancer                          0.852              0.851              0.851                    0.847                      0.853\n",
            "Crohns_Disease                             0.970              0.970              0.965                    0.966                      0.967\n",
            "Depression                                 0.668              0.669              0.664                    0.665                      0.673\n",
            "Diabetes                                   0.714              0.715              0.685                    0.685                      0.712\n",
            "Heart_Failure                              0.812              0.812              0.803                    0.804                      0.805\n",
            "Lung_Cancer                                0.744              0.745              0.747                    0.748                      0.749\n",
            "Multiple_Sclerosis                         0.935              0.938              0.947                    0.951                      0.948\n",
            "Osteoporosis                               0.786              0.786              0.782                    0.782                      0.788\n",
            "Parkinsons                                 0.767              0.769              0.782                    0.783                      0.790\n",
            "Pneumonia                                  0.611              0.611              0.609                    0.609                      0.610\n",
            "Prostate_Cancer                            0.801              0.801              0.799                    0.799                      0.806\n",
            "Psoriasis                                  0.683              0.685              0.720                    0.722                      0.718\n",
            "Rheumatoid_Arthritis                       0.803              0.804              0.799                    0.801                      0.802\n",
            "Secondary_Cancer                           0.598              0.599              0.598                    0.598                      0.600\n",
            "Stroke                                     0.658              0.659              0.657                    0.659                      0.659\n",
            "Thyroid_Disorders                          0.658              0.658              0.652                    0.653                      0.660\n",
            "Ulcerative_Colitis                         0.937              0.935              0.946                    0.943                      0.932\n",
            "\n",
            "================================================================================\n",
            "DIFFERENCES FROM ORIGINAL (Original - Fixed)\n",
            "================================================================================\n",
            "                      Fixed κ\\n(free γ)  Fixed γ\\n(free κ)  Fixed γκ\\n(regularized)  Fixed γκ\\n(unregularized)\n",
            "disease                                                                                                       \n",
            "ASCVD                             0.000              0.003                    0.003                      0.001\n",
            "All_Cancers                       0.000              0.006                    0.006                     -0.001\n",
            "Anemia                            0.001             -0.003                   -0.002                      0.000\n",
            "Anxiety                          -0.002              0.003                    0.002                      0.003\n",
            "Asthma                            0.000              0.003                    0.003                     -0.002\n",
            "Atrial_Fib                        0.001              0.010                    0.010                      0.005\n",
            "Bipolar_Disorder                 -0.019             -0.132                   -0.154                     -0.134\n",
            "Bladder_Cancer                   -0.002             -0.003                   -0.005                     -0.009\n",
            "Breast_Cancer                    -0.001             -0.007                   -0.008                     -0.013\n",
            "CKD                               0.001              0.004                    0.004                      0.008\n",
            "COPD                             -0.001             -0.002                   -0.003                     -0.003\n",
            "Colorectal_Cancer                 0.001              0.001                    0.005                     -0.001\n",
            "Crohns_Disease                    0.000              0.005                    0.004                      0.003\n",
            "Depression                       -0.001              0.004                    0.003                     -0.005\n",
            "Diabetes                         -0.001              0.029                    0.029                      0.002\n",
            "Heart_Failure                     0.000              0.009                    0.008                      0.007\n",
            "Lung_Cancer                      -0.001             -0.003                   -0.004                     -0.005\n",
            "Multiple_Sclerosis               -0.003             -0.012                   -0.016                     -0.013\n",
            "Osteoporosis                      0.000              0.004                    0.004                     -0.002\n",
            "Parkinsons                       -0.002             -0.015                   -0.016                     -0.023\n",
            "Pneumonia                         0.000              0.002                    0.002                      0.001\n",
            "Prostate_Cancer                   0.000              0.002                    0.002                     -0.005\n",
            "Psoriasis                        -0.002             -0.037                   -0.039                     -0.035\n",
            "Rheumatoid_Arthritis             -0.001              0.004                    0.002                      0.001\n",
            "Secondary_Cancer                 -0.001              0.000                    0.000                     -0.002\n",
            "Stroke                           -0.001              0.001                   -0.001                     -0.001\n",
            "Thyroid_Disorders                 0.000              0.006                    0.005                     -0.002\n",
            "Ulcerative_Colitis                0.002             -0.009                   -0.006                      0.005\n",
            "\n",
            "✓ Saved wide format to: /Users/sarahurbut/aladynoulli2/pyScripts/dec_6_revision/new_notebooks/results/all_5_configs_5batches_dynamic_1yr_auc_results_wide.csv\n",
            "\n",
            "================================================================================\n",
            "SUMMARY STATISTICS\n",
            "================================================================================\n",
            "\n",
            "Static 10-Year - Mean AUC:\n",
            "Original\\n(free γ, free κ)    0.621\n",
            "Fixed κ\\n(free γ)             0.622\n",
            "Fixed γ\\n(free κ)             0.616\n",
            "Fixed γκ\\n(regularized)       0.616\n",
            "Fixed γκ\\n(unregularized)     0.622\n",
            "dtype: float64\n",
            "\n",
            "Static 10-Year - Mean Absolute Difference from Original:\n",
            "Fixed κ\\n(free γ)            0.000\n",
            "Fixed γ\\n(free κ)            0.007\n",
            "Fixed γκ\\n(regularized)      0.008\n",
            "Fixed γκ\\n(unregularized)    0.003\n",
            "dtype: float64\n",
            "\n",
            "Dynamic 1-Year - Mean AUC:\n",
            "Original\\n(free γ, free κ)    0.757\n",
            "Fixed κ\\n(free γ)             0.758\n",
            "Fixed γ\\n(free κ)             0.762\n",
            "Fixed γκ\\n(regularized)       0.763\n",
            "Fixed γκ\\n(unregularized)     0.765\n",
            "dtype: float64\n",
            "\n",
            "Dynamic 1-Year - Mean Absolute Difference from Original:\n",
            "Fixed κ\\n(free γ)            0.002\n",
            "Fixed γ\\n(free κ)            0.011\n",
            "Fixed γκ\\n(regularized)      0.012\n",
            "Fixed γκ\\n(unregularized)    0.010\n",
            "dtype: float64\n"
          ]
        }
      ],
      "source": [
        "%run /Users/sarahurbut/aladynoulli2/claudefile/reshape_auc_results.py"
      ]
    }
  ],
  "metadata": {
    "kernelspec": {
      "display_name": "Python 3",
      "language": "python",
      "name": "python3"
    },
    "language_info": {
      "codemirror_mode": {
        "name": "ipython",
        "version": 3
      },
      "file_extension": ".py",
      "mimetype": "text/x-python",
      "name": "python",
      "nbconvert_exporter": "python",
      "pygments_lexer": "ipython3",
      "version": "3.9.21"
    }
  },
  "nbformat": 4,
  "nbformat_minor": 4
}
